Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Herpetoviridae, e.g. herpes simplex virus
Medicinal preparations containing antigens or antibodies
Viral antigens
Herpetoviridae, e.g. herpes simplex virus
Equine rhinopneumonitis virus
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antivirals for DNA viruses for herpes viruses
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Mucosal route
Mucosal route intranasal
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Veterinary vaccine
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
Methods of inactivation or attenuation
Methods of inactivation or attenuation by chemical treatment
Processes for the preparation of sugar derivatives
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Heterocyclic radicals containing only oxygen as ring hetero atoms
Hetero rings containing eight or more ring members, e.g. erythromycins
Preparation of compounds containing saccharide radicals
Preparation of O-glycosides, e.g. glucosides
Preparation of compounds containing saccharide radicals
Preparation of O-glycosides, e.g. glucosides
Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
Preparation of compounds containing saccharide radicals
Preparation of O-glycosides, e.g. glucosides
Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
Avermectin; Milbemycin; Ivermectin; C-076
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
DNA (RNA) vaccination
Medicinal preparations containing antigens or antibodies
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Oryza sp. [rice]
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazoles; Hydrogenated 1,3-diazoles
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
Sulfonylurea
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring aldehyde or ketonic groups (2.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Polycarboxylic acids
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Interleukins [IL]
IL-6
Drugs for dermatological disorders
Antipsoriatics
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Recovery or purification
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Poxviridae, e.g. avipoxvirus
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Methods of production or purification of viral material
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Extraction; Separation; Purification
Extraction; Separation; Purification by chromatography
Ion-exchange chromatography
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Erythropoietin [EPO]
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Extraction; Separation; Purification
Extraction; Separation; Purification by chromatography
Partition-, reverse-phase or hydrophobic interaction chromatography
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Immunoglobulins specific features
Immunoglobulins specific features characterized by their source of isolation or production
Specific host cells or culture conditions, e.g. components, pH or temperature
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Assays involving biological materials from specific organisms or of a specific nature
Translation products from oncogenes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Poxviral vectors, e.g. entomopoxvirus
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Viruses; Subviral particles; Bacteriophages
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antineoplastic agents
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
DNA (RNA) vaccination
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Flavivirus, e.g. yellow fever virus, dengue, JEV
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Poxviral vectors, e.g. entomopoxvirus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Medicinal preparations containing antigens or antibodies
Viral antigens
Poxviridae, e.g. avipoxvirus
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription from viruses
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
Geranylgeranyl diphosphate synthase (2.5.1.29)
Intramolecular oxidoreductases (5.3)
Intramolecular oxidoreductases (5.3) transposing C=C bonds (5.3.3)
Isopentenyl-diphosphate DELTA-isomerase (5.3.3.2)
Technologies for the production of fuel of non-fossil origin
Fuel from waste, e.g. synthetic alcohol or diesel
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for controlling, regulating or enhancing expression of transgenes in plant cells
Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
Vegetative tissue-specific promoters
Root-specific
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the kidneys
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Centrally acting analgesics, e.g. opioids
Drugs for disorders of the nervous system
Antiepileptics; Anticonvulsants
Antiepileptics; Anticonvulsants for petit-mal
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Anti-Parkinson drugs
Drugs for disorders of the nervous system
Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Drugs for disorders of the nervous system
Antidepressants
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for disorders of the blood or the extracellular fluid
Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system
Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Drugs for disorders of the cardiovascular system
Antihypertensives
Uses of viruses
Uses of viruses as vector
Uses of viruses as vector for the expression of a heterologous nucleic acid
Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
Monocarboxylic acids
Acrylic acid; Methacrylic acid
Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
Acids; Metal salts or ammonium salts thereof
Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
Carboxylic acid amides
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
Amides or imides
Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
Acrylamide; Methacrylamide
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Preparations for testing in vivo
Preparation for luminescence or biological staining
Luminescence
Fluorescence in vivo
Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
Preparations for testing in vivo
Preparation for luminescence or biological staining
Luminescence
Fluorescence in vivo
Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
Antibodies
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of breast
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of colon
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of ovaries
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
Culture process characterised by temperature
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Fused cells, e.g. hybridomas
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Animal cells
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of skin, e.g. melanoma
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of liver, pancreas or kidney
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from liver or pancreas
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Screening for compounds of potential therapeutic value
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin the drug being a peptidic cytokine, e.g. an interleukin or interferon
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Enzymes
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin the drug being a peptidic cytokine, e.g. an interleukin or interferon
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Enzymes
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of breast
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for disorders of the metabolism
Antihyperlipidemics
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Reuteri
Technologies having an indirect contribution to adaptation to climate change
Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
Virus mediated transformation
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Viruses
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin the drug being a peptidic cytokine, e.g. an interleukin or interferon
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Enzymes
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from liver or pancreas cancer cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from liver or pancreas
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having three or more nucleosides or nucleotides
Double-stranded nucleic acids or oligonucleotides
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Skin, nerves, brain
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Structure or type of the nucleic acid
Type of nucleic acid
Type of nucleic acid interfering N.A.
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Fungi; Lichens
Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Rhizopus
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Leguminosae or Fabaceae, e.g. soybean, alfalfa or peanut
Pisum sativum [pea]
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Brassicaceae, e.g. canola, broccoli or rucola
Brassica oleraceae, e.g. broccoli or kohlrabi
Vegetative propagation
Processes for modifying genotypes ; Plants characterised by associated natural traits
Methods or apparatus for hybridisation; Artificial pollination ; Fertility
Processes for modifying genotypes ; Plants characterised by associated natural traits
Processes of selection involving genotypic or phenotypic markers; Methods of using phenotypic markers for selection
Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
Methods for regeneration to complete plants
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Flowers
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Ortho-condensed systems
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Drugs for skeletal disorders
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
Dipeptides
Dipeptides with the first amino acid being neutral
Dipeptides with the first amino acid being neutral and aliphatic
Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Processes for modifying phenotypes, e.g. symbiosis with bacteria
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Reclamation of contaminated soil
Reclamation of contaminated soil microbiologically, biologically or by using enzymes
Reclamation of contaminated soil microbiologically, biologically or by using enzymes using fungi or plants
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
In situ
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Penicillium
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Antihyperlipidemics
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the alimentary tract or the digestive system
Antidiarrhoeals
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for disorders of the respiratory system
Drugs for disorders of the respiratory system
Antiasthmatics
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the kidneys
Drugs for genital or sexual disorders; Contraceptives
Drugs for dermatological disorders
Drugs for dermatological disorders
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Drugs for dermatological disorders
Antipsoriatics
Drugs for dermatological disorders
Anti-acne agents
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for skeletal disorders
Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for immunological or allergic disorders
Antiallergic agents
Drugs for disorders of the endocrine system
Drugs for disorders of the blood or the extracellular fluid
Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Drugs for disorders of the blood or the extracellular fluid
Antianaemics
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Bifidobacterium
Longum
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring one-carbon groups (2.1)
Carboxy- and carbamoyl transferases (2.1.3)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Concentration, evaporation or drying
Concentration, evaporation or drying by spraying into a gas stream
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
Other enzymes
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
Cocoa products, e.g. chocolate; Substitutes therefor
Cocoa products, e.g. chocolate; Substitutes therefor making liquid products, e.g. for making chocolate milk drinks and the products for their preparation, pastes for spreading, milk crumb
Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
Synthetic spices, flavouring agents or condiments
Heterocyclic compounds
Heterocyclic compounds having nitrogen as the only hetero atom
Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
Synthetic spices, flavouring agents or condiments
Coffee or cocoa flavours
Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
Taste or flavour enhancing agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Nitrogen as only ring hetero atom containing a six-membered hetero ring
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptococcus ; Enterococcus; Lactococcus
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Testing for antimicrobial activity of a material
Disinfection, sterilisation or deodorisation of air
Disinfection, sterilisation or deodorisation of air
Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
Other air-treating devices
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Aspects relating to disinfection, sterilisation or deodorisation of air
Apparatus features
Connections to a HVAC unit
Aspects relating to disinfection, sterilisation or deodorisation of air
Method-related aspects
Use of chemical compounds for treating air or the like
Disinfection, sterilisation or deodorisation of air
Deodorant compositions
Control inputs relating to air properties
Air quality properties
Odour
Control inputs relating to air properties
Air quality properties
Concentration of specific substances or contaminants
Volatile organic compounds [VOC]
Air-conditioning systems in which conditioned primary air is supplied from one or more central stations to distributing units in the rooms or spaces where it may receive secondary treatment; Apparatus specially designed for such systems
Air-conditioning systems in which conditioned primary air is supplied from one or more central stations to distributing units in the rooms or spaces where it may receive secondary treatment; Apparatus specially designed for such systems characterised by the treatment of the air otherwise than by heating and cooling
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Air quality improvement or preservation, e.g. vehicle emission control or emission reduction by using catalytic converters
Energy efficient heating, ventilation or air conditioning [HVAC]
Efficient control or regulation technologies, e.g. for control of refrigerant flow, motor or heating
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Spirochetes, e.g. Treponema, Leptospira, Borrelia
Drugs for disorders of the alimentary tract or the digestive system
Antidiarrhoeals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Mucosal route
Mucosal route oral/gastrointestinal
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Veterinary vaccine
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Preparation of compounds containing saccharide radicals
Disaccharides
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Oligonucleotides characterized by their use
Polymorphic or mutational markers
Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons
Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
Acyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
Oxygen or sulfur directly attached to a cycloaliphatic ring system
Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
Oxygen or sulfur directly attached to an aromatic ring system
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings condensed with a carbocyclic ring
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Reducing nutritive value; Dietetic products with reduced nutritive value
Addition of substantially indigestible substances, e.g. dietary fibres
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the alimentary tract or the digestive system
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Lactic or propionic acid bacteria
Lactobacillus
Johnsonii
Lactic or propionic acid bacteria
Bifidobacterium
Animalis
Lactic or propionic acid bacteria
Bifidobacterium
Breve
Lactic or propionic acid bacteria
Bifidobacterium
Lactis
Lactic or propionic acid bacteria
Bifidobacterium
Longum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Specific components of cell culture medium
Organic components
Specific components of cell culture medium
Organic components
Sugars
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleosides
Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Medicinal preparations containing organic active ingredients
Nitriles; Isonitriles
Nitriles; Isonitriles having a ring, e.g. verapamil
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Oxidoreductases acting on the CH-CH group of donors (1.3)
Oxidoreductases acting on the CH-CH group of donors (1.3) with NAD+ or NADP+ as acceptor (1.3.1)
Dihydrodipicolinate reductase (1.3.1.26)
Oxidoreductases acting on the CH-NH2 group of donors (1.4)
Oxidoreductases acting on the CH-NH2 group of donors (1.4) with NAD+ or NADP+ as acceptor (1.4.1)
Diaminopimelate dehydrogenase (1.4.1.16)
Oxidoreductases acting on CH or CH2 groups (1.17)
Oxidoreductases acting on CH or CH2 groups (1.17) with NAD+ or NADP+ as acceptor (1.17.1)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Diaminopimelate decarboxylase (4.1.1.20)
Carbon-nitrogen lyases (4.3)
Amine-lyases (4.3.3)
4-Hydroxy-tetrahydrodipicolinate synthase (4.3.3.7)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Drugs for disorders of the alimentary tract or the digestive system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Fungi, e.g. yeasts
Ascomycota
Saccharomycetales, e.g. baker's yeast
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Accessory food factors for animal feeding-stuffs
Organic substances
Amino acids; Derivatives thereof
Accessory food factors for animal feeding-stuffs
Organic substances
Amino acids; Derivatives thereof
Polymeric derivatives, e.g. peptides or proteins
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Yeasts or derivatives thereof
Extracts
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Peptides; Protein hydrolysates
Medicinal preparations containing peptides
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Tripeptides
Glutathione
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Proteins; Peptides; Derivatives or degradation products thereof
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Fungi, e.g. yeasts
Preparations for care of the skin
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Preparation of peptides or proteins
Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Food compositions, function of food ingredients or processes for food or foodstuffs
Food ingredients
Other Organic compounds
Glutathione
Food ingredients
Yeasts
Saccharomyces
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Chemical, physico-chemical or functional or structural properties of particular ingredients
Stabilizers
Antioxidants; Radical scavengers
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Accessory food factors for animal feeding-stuffs
Organic substances
Fatty acids; Fats; Products containing oils or fats
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Fatty acids or derivatives thereof; Fats or oils
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Yeasts or derivatives thereof
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Fungi, e.g. yeasts
Preparations for care of the skin
Production of fats or fatty oils from raw materials
Production of fats or fatty oils from raw materials by extracting
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring one-carbon groups (2.1)
Methyltransferases (general) (2.1.1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
1,4-Alpha-glucan branching enzyme (2.4.1.18)
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Transferases transferring one-carbon groups (2.1)
Methyltransferases (2.1.1)
Phosphatidylethanolamine N-methyltransferase (2.1.1.17)
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
General cosmetic use
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Biological properties of particular ingredients
Enzyme modulators, e.g. Enzyme agonists
Enzyme inhibitors; Enzyme antagonists
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Fungi, e.g. yeasts
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Proline; Hydroxyproline; Histidine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Carbon-oxygen lyases (4.2)
Hydro-lyases (4.2.1)
Prephenate dehydratase (4.2.1.51)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Acyltransferases (2.3)
Acyl groups converted into alkyl on transfer (2.3.3)
2-Isopropylmalate synthase (2.3.3.13)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Chemokines
Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Antineoplastic agents
Antineoplastic agents specific for leukemia
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the blood or the extracellular fluid
Medicinal preparations containing peptides
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DNA sequences coding for fusion proteins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
Preparation of peptides or proteins
Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha-amino functions
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system containing a 2-oxo-thieno[3,4-d]imidazol nucleus, e.g. Biotin
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Thymidine kinase (2.7.1.21)
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on alpha-1,6-glucosidic bonds
Dextranase (3.2.1.11)
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Proteins; Peptides; Derivatives or degradation products thereof
Enzymes
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Products or compounds obtained by genetic engineering
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
Magnoliopsida [dicotyledons]
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid amplification reactions
Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Antineoplastic agents
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing N- glycosyl compounds (3.2.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
Serine endopeptidases (3.4.21)
Kallikreins (3.4.21.34; 3.4.21.35)
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of prostate
Assays involving biological materials from specific organisms or of a specific nature
Enzymes; Proenzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
Serine endopeptidases (3.4.21)
Serine endopeptidases (3.4.21) with definite EC number
Kallikrein (3.4.21.34; 3.4.21.35)
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Animal cells
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Chemistry: molecular biology and microbiology
Kit
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Blood coagulation or fibrinolysis factors
Antineoplastic agents
Drugs for disorders of the blood or the extracellular fluid
Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Medicinal preparations containing peptides
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Foods or foodstuffs containing additives; Preparation or treatment thereof
Microorganisms
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Johnsonii
Lactic or propionic acid bacteria
Bifidobacterium
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Lactobacillus
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss using only lactobacteriaceae for fermentation in combination with enzyme treatment of the milk product; using enzyme treated milk products for fermentation with lactobacteriaceae
Milk preparations; Milk powder or milk powder preparations
Milk preparations; Milk powder or milk powder preparations containing additives
Products from fruits or vegetables; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Cereal-derived products; Malt products; Preparation or treatment thereof
Cereal-derived products
Cereal-derived products; Malt products; Preparation or treatment thereof
Cereal-derived products
Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for immunological or allergic disorders
Immunomodulators
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Paracasei
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Apparatus, or methods of use thereof, for testing or treating seed, roots, or the like, prior to sowing or planting
Coating or dressing seed
Apparatus, or methods of use thereof, for testing or treating seed, roots, or the like, prior to sowing or planting
Immunising seed
Protecting plants
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
N-acyl derivatives
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof containing a OCON< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
Drug, bio-affecting and body treating compositions
Insect repellent
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides containing at least one oxygen or sulfur atom being directly attached to the same aromatic ring system
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3 with two oxygen atoms in positions 1,3, condensed with a carbocyclic ring
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
Triazoles; Hydrogenated triazoles
1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Nucleic acids vectors
Plasmid DNA
Plasmid DNA for bacteria
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
Pyruvate dehydrogenase (NADP+) (1.2.1.51)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with a disulfide as acceptor (1.2.4)
Pyruvate dehydrogenase (acetyl-transferring) (1.2.4.1)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Ethers; Compounds having groups, groups or groups
Ethers
Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
Antiparasitic agents
Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Antimalarials
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with a leaven or a composition containing acidifying bacteria
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
Chewing gum
Chewing gum characterised by the composition containing organic or inorganic compounds
Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Cereal-derived products; Malt products; Preparation or treatment thereof
Cereal-derived products
Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for immunological or allergic disorders
Antiallergic agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Lactic or propionic acid bacteria
Bifidobacterium
Longum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Glucans
Chitin, chitosan
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Pectin
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Fructosans, e.g. inulin
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Preparation of compounds containing saccharide radicals
Monosaccharides
Processes involving microorganisms of different genera in the same process, simultaneously
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
4-Alpha-glucanotransferase (2.4.1.25)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Glucokinase (2.7.1.2)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Tagatose-6-phosphate kinase (2.7.1.144)
Carbon-carbon lyases (4.1)
Aldehyde-lyases (4.1.2)
Tagatose-bisphosphate aldolase (4.1.2.40)
Intramolecular oxidoreductases (5.3)
Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
Glucose-6-phosphate isomerase (5.3.1.9)
Intramolecular transferases (5.4)
Phosphotransferases (phosphomutases) (5.4.2)
Phosphoglucomutase (5.4.2.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of compounds containing saccharide radicals
Monosaccharides
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Tagatose-6-phosphate kinase (2.7.1.144)
Carbon-carbon lyases (4.1)
Aldehyde-lyases (4.1.2)
Tagatose-bisphosphate aldolase (4.1.2.40)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing saccharide radicals
Monosaccharides
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Tagatose-6-phosphate kinase (2.7.1.144)
Carbon-carbon lyases (4.1)
Aldehyde-lyases (4.1.2)
Tagatose-bisphosphate aldolase (4.1.2.40)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Glucokinase (2.7.1.2)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
Removal of unwanted matter, e.g. deodorisation or detoxification
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Paracasei
Lactic or propionic acid bacteria
Lactobacillus
Pentosus
Lactic or propionic acid bacteria
Streptococcus, lactococcus
Lactis
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus subtilis ; Hay bacillus; Grass bacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Homoserine dehydrogenase (1.1.1.3)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for weanlings
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Preparations for care of the skin
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Hydrolases acting on acid anhydrides (3.6)
Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
Phosphoribosyl-ATP diphosphatase (3.6.1.31)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Pentosyltransferases (2.4.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Glycosyltransferases (2.4)
Pentosyltransferases (2.4.2)
ATP phosphoribosyltransferase (2.4.2.17)
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription from bacteria
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Preparation of nitrogen-containing organic compounds
Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
Preparation of oxygen-containing organic compounds
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
L-Lactate dehydrogenase (1.1.1.27)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Viruses; Subviral particles; Bacteriophages
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Bacteriophages
Details
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Bacteriophages
Details
Methods of production or purification of viral material
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
Chemical or biological purification of waste gases
General processes for purification of waste gases; Apparatus or devices specially adapted therefor
Biological processes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Reactants
Specific microorganisms
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus subtilis ; Hay bacillus; Grass bacillus
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Penicillium
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
Saturated carboxylic acids or thio analogues thereof; Derivatives thereof polybasic
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Penicillium
Disinfectants; Antimicrobial compounds or mixtures thereof
Plant growth regulators
Fungicides
Nematocides
Arthropodicides
Insecticides
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Medicinal preparations containing antigens or antibodies
Viral antigens
Hepatitis virus
Medicinal preparations containing antigens or antibodies
Viral antigens
Hepatitis virus
Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
Hepadnaviridae, e.g. hepatitis B virus
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
Hepatitis C virus; Hepatitis G virus
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
Medicinal preparations containing antigens or antibodies
Viral antigens
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Reverse transcribing DNA viruses
Details
Hepadnaviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Reverse transcribing DNA viruses
Details
Hepadnaviridae
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Reverse transcribing DNA viruses
Details
Hepadnaviridae
Orthohepadnavirus, e.g. hepatitis B virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Reverse transcribing DNA viruses
Details
Hepadnaviridae
Orthohepadnavirus, e.g. hepatitis B virus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Ligases forming carbon-nitrogen bonds (6.3)
Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
Glutamate-ammonia ligase (6.3.1.2)
Libraries per se, e.g. arrays, mixtures
Libraries containing only organic compounds
Libraries containing peptides or polypeptides, or derivatives thereof
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Isolating an individual clone by screening libraries
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Libraries per se, e.g. arrays, mixtures
Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Colony-stimulating factor [CSF]
Granulocyte CSF; Granulocyte-macrophage CSF
Antineoplastic agents
Antineoplastic agents specific for leukemia
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DNA sequences coding for fusion proteins
DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
Fusion polypeptide
Fusion polypeptide containing domain for protein-protein interaction
Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging using microorganisms or enzymes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons acyclic
Methane
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus brevis
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Technologies for the production of fuel of non-fossil origin
Fuel from waste, e.g. synthetic alcohol or diesel
Technologies relating to agriculture, livestock or agroalimentary industries
Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
Re-use of by-products of food processing for fodder production
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
Glyphosate
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
Phosphinotricin
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Phenylalanine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Proline; Hydroxyproline; Histidine
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Alcohol dehydrogenase (NADP+) (1.1.1.2), i.e. aldehyde reductase
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Drugs for dermatological disorders
Preparations for care of the skin
Anti-ageing preparations
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Proline; Hydroxyproline; Histidine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with a quinone or similar compound as acceptor (1.1.5)
Glycerol-3-phosphate dehydrogenase (1.1.5.3)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Glycerol kinase (2.7.1.30)
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the respiratory system
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the prostate
Drugs for genital or sexual disorders; Contraceptives
Drugs for skeletal disorders
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Agonist effect on antigen
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Mollicutes, e.g. Mycoplasma, Erysipelothrix
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Mycobacterium, e.g. Mycobacterium tuberculosis
Medicinal preparations containing antigens or antibodies
Viral antigens
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Veterinary vaccine
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Avulavirus, e.g. Newcastle disease virus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Mycoplasma
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Mycoplasma
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on beta-1,4-glucosidic bonds
Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Other raw materials for the preparation of beer
Enzymes
Other raw materials for the preparation of beer
Enzymes
Beta-glucanase or functionally equivalent enzymes
Preparation of wort
Preparation or treatment of the mash
Methods for increasing the alcohol content of fermented solutions or alcoholic beverages
Methods for increasing the alcohol content of fermented solutions or alcoholic beverages by distillation
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on beta-1,4-glucosidic bonds
Endo-1,3(4)-beta-glucanase (3.2.1.6)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Xylanases
Endo-1,4-beta-xylanase (3.2.1.8)
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,3(4)-beta-glucanase (3.2.1.6)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,4-beta-xylanase (3.2.1.8)
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Penicillium
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Trichoderma
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing antigens or antibodies
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Polygalacturonase (3.2.1.15)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for controlling, regulating or enhancing expression of transgenes in plant cells
Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Blood; Artificial blood
Erythrocytes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Alpha-galactosidase (3.2.1.22)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Alpha-N-acetylgalactosaminidase (3.2.1.49)
Medicinal preparations containing peptides
Fusion polypeptide
Fusion polypeptide
Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
Fusion polypeptide
Fusion polypeptide containing domain for protein-protein interaction
Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving proteins of known structure or function as defined in the subgroups
Details
Lipocortins
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
Drugs for disorders of the respiratory system
Drugs for disorders of the blood or the extracellular fluid
Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing peptides
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Fusion polypeptide
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
Drugs for dermatological disorders
Antipsoriatics
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for immunological or allergic disorders
Antiallergic agents
Medicinal preparations containing peptides
Medicinal preparations containing organic active ingredients
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic orhydroximic acids
Carboxylic acids, e.g. valproic acid
Carboxylic acids, e.g. valproic acid having an amino group
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Viruses
HIV or HTLV
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for controlling, regulating or enhancing expression of transgenes in plant cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Interleukins [IL]
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for disorders of the nervous system
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Bacteria
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
Medicinal preparations containing peptides
Medicinal preparations containing antigens or antibodies
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Drug, bio-affecting and body treating compositions
Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
Chemistry: molecular biology and microbiology
Kit
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Proteins from microorganisms
Bacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
Containers for the purpose of retaining a material to be analysed, e.g. test tubes
Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Apparatus
Features relating to the solid phase supports
Walls of reactor vessels
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Apparatus
Features relating to the solid phase supports
Essentially linear supports
Essentially linear supports in the shape of tapes
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Apparatus
Features relating to the solid phase supports
Essentially linear supports
Essentially linear supports in the shape of elongated tubes
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Apparatus
Features relating to the solid phase supports
Sheets
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Apparatus
Features relating to the solid phase supports
Sheets
Sheets essentially square
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Apparatus
Features relating to the solid phase supports
Sheets
Sheets essentially rectangular
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Apparatus
Features relating to the solid phase supports
Sheets
Sheets in the shape of disks
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Features relative to the processes being carried out
Parallel processes
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Features relative to the processes being carried out
Solid-phase processes
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Features relative to the processes being carried out
Making arrays on substantially continuous surfaces
Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Features relative to the processes being carried out
Making arrays on substantially continuous surfaces
Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
The surface being organic
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Features relative to the processes being carried out
Making arrays on substantially continuous surfaces
Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
Delimitation of the attachment areas
Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Features relative to the processes being carried out
Making arrays on substantially continuous surfaces
Two-dimensional arrays
Chemical, physical or physico-chemical processes in general; Their relevant apparatus
Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
Means for controlling the apparatus of the process
Processes involving means for analysing and characterising the products
Processes involving means for analysing and characterising the products separated from the reactor apparatus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Specific hybridization probes
Specific hybridization probes for retroviruses
Reverse transcribing RNA viruses
Details
Retroviridae
Human Immunodeficiency Virus, HIV
Methods of production or purification of viral material
Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Regulators; Modulating activity
Inhibitors; Suppressors
Drugs for dermatological disorders
Antipsoriatics
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for disorders of the senses
Ophthalmic agents
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antineoplastic agents
Drugs for disorders of the cardiovascular system
Medicinal preparations containing peptides
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Animal cells
HLA or MHC typing
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Chemistry: analytical and immunological testing
Fertility tests
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Proteins from mammals or birds
Reproductive organs or embryos
Sperm
Ovary; eggs; embryos
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of steroids
Hydroxylating
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
New or modified breeds of vertebrates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
New or modified breeds of vertebrates
Genetically modified vertebrates, e.g. transgenic
Knock-in vertebrates, e.g. humanised vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Colony-stimulating factor [CSF]
Granulocyte CSF; Granulocyte-macrophage CSF
Modified animals
Humanized animals
Genetically modified animals
Genetically modified animals
Animals comprising random inserted nucleic acids (transgenic)
Animals characterised by species
Mammal
Caprine
Animals characterised by purpose
Animal expressing industrially exogenous proteins
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Drugs for dermatological disorders
Drugs for dermatological disorders
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing peptides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus thuringiensis
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Ligases forming carbon-carbon bonds (6.4)
Ligases forming carbon-carbon bonds (6.4.1)
Pyruvate carboxylase (6.4.1.1)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Herpetoviridae, e.g. herpes simplex virus
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Cytomegalovirus, e.g. human herpesvirus 5
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Cytomegalovirus, e.g. human herpesvirus 5
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Cytomegalovirus, e.g. human herpesvirus 5
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Cytomegalovirus, e.g. human herpesvirus 5
Methods of inactivation or attenuation
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
DNA (RNA) vaccination
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Erwinia (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Erwinia
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving cytokines
Interleukins [IL]
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Transferrins, e.g. lactoferrins, ovotransferrins
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
Coordinates from 3D structures of peptides, e.g. proteins or enzymes
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Dry feed
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the alimentary tract or the digestive system
Lactic or propionic acid bacteria
Lactobacillus
Lactic or propionic acid bacteria
Lactobacillus
Ruminis
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Lactobacillus
Lactobacillus acidophilus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Biochemical treatment
Treatment with microorganisms
Slime forming bacteria; Exopolysaccharide or thickener producing bacteria, ropy cultures, so-called filant strains
Lactic or propionic acid bacteria
Streptococcus, lactococcus
Thermophilus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptococcus ; Enterococcus; Lactococcus
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Igs containing Ig-regions, -domains or -residues form different species
Igs containing CDR-residues from one specie grafted between FR-residues from another
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
Hepadnaviridae, e.g. hepatitis B virus
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Igs containing Ig-regions, -domains or -residues form different species
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Herpetoviridae, e.g. herpes simplex virus
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antivirals for DNA viruses for herpes viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus avirulent or attenuated
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Methods of inactivation or attenuation
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Stable introduction of foreign DNA into chromosome
Stable introduction of foreign DNA into chromosome using homologous recombination
Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
Nucleic acids vectors
Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription from viruses
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
D-Amino acid oxidase (1.4.3.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving hydantoins or carbamoylamino compounds
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Lectin superfamily, e.g. CD23, CD72
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Blood cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Internalization into the cell
Fusion polypeptide
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Purification or manufacturing processes for gene therapy compositions
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Special targeting system for viral vectors
Vectors comprising a targeting moiety
Vectors comprising as targeting moiety peptide derived from defined protein
Vectors comprising as targeting moiety peptide derived from defined protein from bacteria
Vectors comprising a targeting moiety
Vectors comprising as targeting moiety peptide derived from defined protein
Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
Vectors comprising a targeting moiety
Vectors comprising as targeting moiety peptide derived from defined protein
Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
General methods for preserving meat, sausages, fish or fish products
Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
Organic compounds; Microorganisms; Enzymes
Microorganisms; Enzymes; Antibiotics
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for ruminants
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Tumour cells, irrespective of tissue of origin
Bacteriophages
Details
Details ssRNA Bacteriophages positive-sense
Leviviridae
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Purification or manufacturing processes for gene therapy compositions
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Specific components of cell culture medium
Serum-free medium, which may still contain naturally-sourced components
Genetically modified cells
Cells for production
Reverse transcribing RNA viruses
Details
Retroviridae
Gammaretrovirus, e.g. murine leukeamia virus
Virus like particles [VLP]
Reverse transcribing RNA viruses
Details
Retroviridae
Gammaretrovirus, e.g. murine leukeamia virus
Methods of production or purification of viral material
Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Poxviridae, e.g. avipoxvirus
Vaccinia virus or variola virus
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for influenza or rhinoviruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antivirals for DNA viruses for herpes viruses
Antineoplastic agents
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus expressing foreign proteins
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
Techniques for producing new mammalian cloned embryos
Bovine embryos
Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
New or modified breeds of vertebrates
Genetically modified vertebrates, e.g. transgenic
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
Genetically modified animals
Animals comprising random inserted nucleic acids (transgenic)
Animals characterised by species
Mammal
Bovine
Animals characterised by purpose
Animal expressing industrially exogenous proteins
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Triglyceride splitting, e.g. by means of lipase
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Fatty acids by hydrolysis of fatty acid esters
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Diacylglycerol-sterol O-acyltransferase (2.3.1.73)
Hydrolases acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Triacylglycerol lipase (3.1.1.3)
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for rodents
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for weanlings
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Drugs for disorders of the endocrine system
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Preparation of elements or inorganic compounds except carbon dioxide
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Obtaining copper
Hydrometallurgy
Leaching or slurrying
Leaching or slurrying with acids or salts thereof
Leaching or slurrying with acids or salts thereof containing sulfur
Extraction of metal compounds from ores or concentrates by wet processes
Extraction of metal compounds from ores or concentrates by wet processes with the aid of microorganisms or enzymes, e.g. bacteria or algae
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Technologies related to metal processing
Recycling
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Plant cells or fungi
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from fungi
Screening for compounds of potential therapeutic value
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Viruses
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Methods of inactivation or attenuation
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from viruses
RNA viruses
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Foods or foodstuffs containing additives; Preparation or treatment thereof
Microorganisms
Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
Removal of unwanted matter, e.g. deodorisation or detoxification
Removal of unwanted matter, e.g. deodorisation or detoxification using microorganisms
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Rickettsiales, e.g. Anaplasma
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Specific bacteria not otherwise provided for
Medicinal preparations containing antigens or antibodies
Viral antigens
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Rickettsiales (O)
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Veterinary vaccine
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Organic adjuvants
Emulsions, e.g. Freund's adjuvant, MF59
Medicinal preparations containing antigens or antibodies
Multivalent vaccine
Medicinal preparations containing antigens or antibodies
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Birnaviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Birnaviridae
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Amaryllidaceae, e.g. onion
Allium cepa [onion]
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Stems
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Roots
Medicinal preparations containing antigens or antibodies
Vertebrate antigens
Cancer antigens
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Drugs for disorders of the respiratory system
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the prostate
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the bladder
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the kidneys
Drugs for genital or sexual disorders; Contraceptives
Drugs for dermatological disorders
Drugs for disorders of the nervous system
Drugs for disorders of the senses
Ophthalmic agents
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Animal cells
Tumor cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Animal cells
Animal cells expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Organic adjuvants
Proteins; Peptides
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Organic adjuvants
Cytokines; Lymphokines; Interferons
Interleukins
Medicinal preparations containing antigens or antibodies
Vaccine for a specifically defined cancer
Medicinal preparations containing antigens or antibodies
Vaccine for a specifically defined cancer
Skin, melanoma
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Recovery or purification
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Methods of production or purification of viral material
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Methods of inactivation or attenuation
Methods of inactivation or attenuation by genetic engineering
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing organic active ingredients
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic orhydroximic acids
Carboxylic acids, e.g. valproic acid
Carboxylic acids, e.g. valproic acid having an amino group
Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
Medicinal preparations containing organic active ingredients
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic orhydroximic acids
Carboxylic acids, e.g. valproic acid
Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Apparatus, or methods of use thereof, for testing or treating seed, roots, or the like, prior to sowing or planting
Coating or dressing seed
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
Encapsulated embryos for plant reproduction, e.g. artificial seeds
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Leaves
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Lolium [ryegrass]
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
Accessory food factors for animal feeding-stuffs
Organic substances
Steroids
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Accessory food factors for animal feeding-stuffs
Organic substances
Vitamins
Accessory food factors for animal feeding-stuffs
Organic substances
Enzymes
Accessory food factors for animal feeding-stuffs
Inorganic substances, e.g. oligoelements
Shaping or working-up of animal feeding-stuffs
Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Hydrolases (3)
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the alimentary tract or the digestive system
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
3-Phytase (3.1.3.8)
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
4-Phytase (3.1.3.26), i.e. 6-phytase
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
5-Phytase (3.1.3.72)
Shaping or working-up of animal feeding-stuffs
Shaping or working-up of animal feeding-stuffs by extrusion
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Antineoplastic agents
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Poxviridae
Orthopoxvirus, e.g. vaccinia virus, variola
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Helmets; Helmet covers ; Other protective head coverings
Parts, details or accessories of helmets
Chin straps or similar retention devices
Helmets; Helmet covers ; Other protective head coverings
Parts, details or accessories of helmets
Chin straps or similar retention devices
Occipital retention systems
Helmets; Helmet covers ; Other protective head coverings
Parts, details or accessories of helmets
Linings
Suspension devices
Size adjustment devices
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Rickettsiales, e.g. Anaplasma
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from lung cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from liver or pancreas cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Antineoplastic agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Internalization into the cell
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients stabilising the active ingredients
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Spore forming or isolating processes
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Reducing nutritive value; Dietetic products with reduced nutritive value
Addition of substantially indigestible substances, e.g. dietary fibres
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Antihyperlipidemics
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Food compositions, function of food ingredients or processes for food or foodstuffs
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Antineoplastic agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
Bridged systems
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Oligonucleotides characterized by their use
Polymorphic or mutational markers
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons
Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
Acyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
Biocides, pest repellants or attractants, or plant growth regulators, containing compounds containing the group, wherein m+n>=1, both X together may also mean Y or a direct carbon-to-carbon bond, and the carbon atoms marked with an asterisk are not part of any ring system other than that which may be formed by the atoms X, the carbon atoms in square brackets being part of any acyclic or cyclic structure, or the group, wherein A means a carbon atom or Y, n>=0, and not more than one of these carbon atoms being a member of the same ring system, e.g. juvenile insect hormones or mimics thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
Magnoliopsida [dicotyledons]
Apiaceae or Umbelliferae [Carrot family], e.g. parsley, caraway, dill, lovage, fennel or snakebed
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using fungi
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons cyclic
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons cyclic
Preparation of hydrocarbons or halogenated hydrocarbons cyclic aromatic
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons acyclic
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons acyclic
Unsaturated compounds, i.e. alkenes, alkynes or allenes
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Butanols
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carbonyl group
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carbonyl group
Ketones
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carbonyl group
Ketones
Acetone-containing products
Acetone-containing products produced from substrate containing grain or cereal material
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Specific components of cell culture medium
Atmosphere, e.g. low oxygen conditions
Specific components of cell culture medium
Organic components
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Accessory food factors for animal feeding-stuffs
Organic substances
Accessory food factors for animal feeding-stuffs
Organic substances
Amino acids; Derivatives thereof
Accessory food factors for animal feeding-stuffs
Organic substances
Sugars; Polysaccharides
Accessory food factors for animal feeding-stuffs
Inorganic substances, e.g. oligoelements
Compounds of alkaline earth metals, e.g. magnesium
Shaping or working-up of animal feeding-stuffs
Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
Shaping or working-up of animal feeding-stuffs
Shaping or working-up of animal feeding-stuffs by extrusion
Shaping or working-up of animal feeding-stuffs
Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for ruminants
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for weanlings
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Food compositions, function of food ingredients or processes for food or foodstuffs
Food ingredients
Acid
Amino acid
Glutamic acid
Food ingredients
Polysaccharides, gums
Gums
Alginate
Food ingredients
Sugars, e.g. mono-, di-, tri-, tetra-saccharides
Saccharose, sucrose
Food ingredients
Sugars, e.g. mono-, di-, tri-, tetra-saccharides
Trehalose
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Anti-Parkinson drugs
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
Systems in which incident light is modified in accordance with the properties of the material investigated
Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing liquids, e.g. polluted water
Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
Systems in which incident light is modified in accordance with the properties of the material investigated
Specular reflectivity
Attenuated total reflection
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Neurological disorders, e.g. Alzheimer's disease
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving proteins of known structure or function as defined in the subgroups
Details
Amyloid plaque core protein
Detection or diagnosis of diseases
Neurological disorders
Movement disorders, e.g. Parkinson, Huntington, Tourette
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Preparation of compounds containing saccharide radicals
Disaccharides
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
Phosphatidylglycerophosphatase (3.1.3.27)
Hydrolases acting on acid anhydrides (3.6)
Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
Undecaprenyl-diphosphate phosphatase (3.6.1.27)
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Animals; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Paenibacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Processes for modifying phenotypes, e.g. symbiosis with bacteria
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Plant growth regulators
Other organic fertilisers
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Technologies relating to agriculture, livestock or agroalimentary industries
Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
Dinitrogen oxide [N2O], e.g. using aquaponics, hydroponics or efficiency measures
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Drugs for disorders of the alimentary tract or the digestive system
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Animalis
Lactic or propionic acid bacteria
Lactobacillus
Brevis
Lactic or propionic acid bacteria
Lactobacillus
Curvatus
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Lactic or propionic acid bacteria
Lactobacillus
Reuteri
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus brevis
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptococcus ; Enterococcus; Lactococcus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing saccharide radicals
Monosaccharides
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Phosphorylase (2.4.1.1)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Polyphosphate--glucose phosphotransferase (2.7.1.63)
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Alpha-amylase (3.2.1.1)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Pullulanase (3.2.1.41)
Racemaces and epimerases (5.1)
Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
Intramolecular oxidoreductases (5.3)
Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
Glucose-6-phosphate isomerase (5.3.1.9)
Intramolecular transferases (5.4)
Phosphotransferases (phosphomutases) (5.4.2)
Phosphoglucomutase (5.4.2.2)
Intramolecular transferases (5.4)
Phosphotransferases (phosphomutases) (5.4.2)
Phosphomannomutase (5.4.2.8)
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
General methods of protein analysis not limited to specific proteins or families of proteins
Methods of protein analysis involving mass spectrometry
Methods of protein analysis involving laser desorption ionisation mass spectrometry
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Arthrobacter
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Xanthomonas
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from plants
Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Pseudomonas
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Processes for modifying phenotypes, e.g. symbiosis with bacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Hordeum vulgarus [barley]
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Lolium [ryegrass]
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Triticum sp. [wheat]
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Technologies relating to agriculture, livestock or agroalimentary industries
Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
Dinitrogen oxide [N2O], e.g. using aquaponics, hydroponics or efficiency measures
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Processes for modifying phenotypes, e.g. symbiosis with bacteria
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Isolating an individual clone by screening libraries
Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Isolating an individual clone by screening libraries
Screening libraries by altering the phenotype or phenotypic trait of the host
ICT specially adapted for sequence analysis involving nucleotides or amino acids
Sequence alignment; Homology search
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Xanthomonas
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring nitrogenous groups (2.6)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Pyrimidine nucleotides
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Arylamine N-acetyltransferase (2.3.1.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
N,N'-Diacetyllegionaminate synthase (2.5.1.101)
Transferases transferring nitrogenous groups (2.6)
Transaminases (2.6.1)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
N-Acetylglucosamine-6-phosphate deacetylase (3.5.1.25)
Hydrolases acting on acid anhydrides (3.6)
Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
UDP-sugar diphosphatase (3.6.1.45)
Carbon-oxygen lyases (4.2)
Hydro-lyases (4.2.1)
UDP-N-acetylglucosamine 4,6-dehydratase (configuration-retaining) (4.2.1.135)
Racemaces and epimerases (5.1)
Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Cannabaceae, e.g. cannabis
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Processes for modifying phenotypes, e.g. symbiosis with bacteria
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Leaves
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Pseudomonas
Fungicides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Processes for modifying phenotypes, e.g. symbiosis with bacteria
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Hordeum vulgarus [barley]
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Lolium [ryegrass]
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Paenibacillus
Disinfectants; Antimicrobial compounds or mixtures thereof
Plant growth regulators
Fungicides
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Unicellular algae isolates
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Production of fats or fatty oils from raw materials
Pretreatment
Production of fats or fatty oils from raw materials
Pretreatment
Pretreatment by enzymes or microorganisms, living or dead
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Microorganisms ; Processes using microorganisms
Algae ; Processes using algae
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Lung
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
[b, e]- or [b, f]-condensed with six-membered rings
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Eicosapentaenoic acids [EPA]
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
Enzymes or microbial cells immobilised on or in an organic carrier
Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
Enzymes or microbial cells immobilised on or in an organic carrier
Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Recycling of catalysts
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Fungi, e.g. yeasts
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Antihyperlipidemics
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Antihypertensives
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
Enzymes or microbial cells immobilised on or in an organic carrier
Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
Enzymes or microbial cells immobilised on or in an organic carrier
Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Compounds containing amino and carboxyl groups bound to the same carbon skeleton
Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
Esters of carbamic acids
Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
Compounds having carboxyl groups bound to carbon atoms of rings other than sixmembered aromatic rings and containing any of the groups OH, Ometal, CHO, keto, ether, groups, groups, or groups
Saturated compounds containing hydroxy or O-metal groups
Saturated compounds containing hydroxy or O-metal groups polycyclic
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Halogen-containing esters
Halogen-containing esters of saturated acids
Halogen-containing esters of saturated acids containing rings in the acid moiety
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Systems containing at least three condensed rings
Ring systems containing bridged rings
Ring systems containing bridged rings containing three rings
Ring systems containing bridged rings containing three rings containing only six-membered rings
Adamantanes
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing organic active ingredients
Amines
Amidines (), e.g. guanidine (H2NC(=NH)NH2), isourea (N=C(OH)NH2), isothiourea (N=C(SH)NH2)
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the endocrine system
Drugs for disorders of the endocrine system of the pancreatic hormones
Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Bifidobacterium
Animalis
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Phosphoglycerides
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Linoleic acids [18:2[n-6]]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Eicosapentaenoic acids [EPA]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Docosahexenoic acids [DHA]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Refining fats or fatty oils
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
Phosphatide compositions for foodstuffs, e.g. lecithin
Refining fats or fatty oils
Refining fats or fatty oils by enzymes or microorganisms, living or dead
Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Triglyceride splitting, e.g. by means of lipase
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Fatty acids by hydrolysis of fatty acid esters
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Phosphoglycerides
Hydrolases acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Triacylglycerol lipase (3.1.1.3)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Fungi, e.g. yeasts
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for dermatological disorders
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for immunological or allergic disorders
Antiallergic agents
Preparations for care of the skin
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Lipids, e.g. triglycerides; Polycationic carriers
Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Pre-targeting systems involving an antibody for targeting specific cells
Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin immunoglobulins having two or more different antigen-binding sites or multifunctional antibodies
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Fusion polypeptide
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Amino-acid N-acetyltransferase (2.3.1.1)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
Acetylornithine deacetylase (3.5.1.16)
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Triglyceride splitting, e.g. by means of lipase
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on alpha -1,4-glucosidic bonds
Amylases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on alpha -1,4-glucosidic bonds
Amylases
Alpha-amylase (3.2.1.1.)
Alpha-amylase (3.2.1.1.) from microbiological source
Fungal source
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on beta-1,4-glucosidic bonds
Chitinase (3.2.1.14)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Xylanases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Alpha-amylase (3.2.1.1)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,4-beta-xylanase (3.2.1.8)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Chitinase (3.2.1.14)
Chemical treatment prior to tanning
Facilitating unhairing, e.g. by painting, by liming
Enzymatic unhairing
Manufacture or treatment of nanostructures
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Nanotechnology
Manufacture, treatment, or detection of nanostructure
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
O-Phosphoserine sulfhydrylase (2.5.1.65)
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
Phosphoserine phosphatase (3.1.3.3)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Accessory food factors for animal feeding-stuffs
Organic substances
Colouring agents, e.g. pigmenting or dyeing agents
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
Removing undesirable substances, e.g. bitter substances
Drugs for disorders of the metabolism
Nutrients, e.g. vitamins, minerals
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
Specific components of cell culture medium
Atmosphere, e.g. low oxygen conditions
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
Oxidoreductases acting on the CH-NH group of donors (1.5)
Oxidoreductases acting on the CH-NH group of donors (1.5) with other acceptors (1.5.99)
Proline dehydrogenase (1.5.99.8)
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Recycling of unreacted starting or intermediate materials
Accessory food factors for animal feeding-stuffs
Organic substances
Colouring agents, e.g. pigmenting or dyeing agents
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
Colouring or decolouring of foods
Addition of dyes or pigments, e.g. in combination with optical brighteners
Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
Drugs for dermatological disorders
Antioxidants, e.g. antiradicals
Drugs for disorders of the senses
Ophthalmic agents
Antineoplastic agents
General protective or antinoxious agents
Free radical scavengers or antioxidants
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Acetyl-CoA C-acyltransferase (2.3.1.16)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Oxidoreductases acting on the CH-CH group of donors (1.3)
Oxidoreductases acting on the CH-CH group of donors (1.3) with NAD+ or NADP+ as acceptor (1.3.1)
Phosphatidylcholine desaturase (1.3.1.35)
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Peptides; Protein hydrolysates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of peptides or proteins
Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Lactic or propionic acid bacteria
Lactobacillus
Helveticus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring one-carbon groups (2.1)
Carboxy- and carbamoyl transferases (2.1.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring nitrogenous groups (2.6)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with a carboxyl group as acceptor (2.7.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
N-Acetyl-gamma-glutamyl-phosphate reductase (1.2.1.38)
Transferases transferring one-carbon groups (2.1)
Carboxy- and carbamoyltransferases (2.1.3)
Ornithine carbamoyltransferase (2.1.3.3)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Glutamate N-acetyltransferase (2.3.1.35)
Transferases transferring nitrogenous groups (2.6)
Transaminases (2.6.1)
Ornithine aminotransferase (2.6.1.13)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with a carboxy group as acceptor (2.7.2)
Acetylglutamate kinase (2.7.2.8)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
Agrobacterium mediated transformation
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring one-carbon groups (2.1)
Methyltransferases (general) (2.1.1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Transferases transferring one-carbon groups (2.1)
Methyltransferases (2.1.1)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
NAD+ kinase (2.7.1.23)
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
Carrier-bound or immobilised peptides; Preparation thereof
Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
F(ab')2
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Fab or Fab'
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Disulfide-stabilized antibody (dsFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Medicinal preparations containing organic active ingredients
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
Retinol compounds, e.g. vitamin A
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Accessory food factors for animal feeding-stuffs
Accessory food factors for animal feeding-stuffs
Organic substances
Colouring agents, e.g. pigmenting or dyeing agents
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Egg products; Preparation or treatment thereof
Egg products; Preparation or treatment thereof
Addition or treatment with microorganisms or enzymes
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Technologies for solid waste management
Bio-organic fraction processing; Production of fertilisers from the organic fraction of waste or refuse
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Homoserine O-acetyltransferase (2.3.1.31)
Production of fats or fatty oils from raw materials
Production of fats or fatty oils from raw materials by extracting
Production of fats or fatty oils from raw materials by extracting using super critical gases or vapours
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
Accessory food factors for animal feeding-stuffs
Organic substances
Fatty acids; Fats; Products containing oils or fats
Shaping or working-up of animal feeding-stuffs
Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
Shaping or working-up of animal feeding-stuffs
Shaping or working-up of animal feeding-stuffs by extrusion
Production of fats or fatty oils from raw materials
Production of fats or fatty oils from raw materials by extracting
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Epidermal cells, skin cells; Cells of the oral mucosa
Melanocytes
Specific components of cell culture medium
Inorganic components
Metals; Metal chelators
Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
Calcium; Ca chelators; Calcitonin
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from epidermal cells, from skin cells, from oral mucosa cells
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from epidermal cells, from skin cells, from oral mucosa cells from keratinocytes
Special means in or on valves or other cut-off apparatus for indicating or recording operation thereof, or for enabling an alarm to be given
Electrical or magnetic means
Electrical or magnetic means for measuring valve parameters
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Nitrogen as only ring hetero atom containing a six-membered hetero ring
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DNA sequences coding for fusion proteins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Oxidoreductases acting on the CH-NH2 group of donors (1.4)
Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
L-Aspartate oxidase (1.4.3.16)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
Quinolinate synthase (2.5.1.72)
Special means in or on valves or other cut-off apparatus for indicating or recording operation thereof, or for enabling an alarm to be given
Hydraulic or pneumatic means
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with yeasts
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Apparatus, or methods of use thereof, for testing or treating seed, roots, or the like, prior to sowing or planting
Immunising seed
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings condensed with a carbocyclic ring
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom containing OCOO groups; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Fusarium
Treating radioactively contaminated material; Decontamination arrangements therefor
Treating liquids
Processing
Processing by absorption; by adsorption; by ion-exchange
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
Sulfones; Sulfoxides
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Drugs for disorders of the metabolism
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
1,3-Thiazoles; Hydrogenated 1,3-thiazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof the nitrogen atom being part of a heterocyclic ring
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing acyclic or cycloaliphatic radicals
Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
Phosphorus; Compounds thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Other inorganic fertilisers
Other inorganic fertilisers containing trace elements
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on iron-sulfur proteins as donor (1.18)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on reduced flavodoxin as donor (1.19)
Oxidoreductases acting on iron-sulfur proteins as donors (1.18)
Oxidoreductases acting on iron-sulfur proteins as donors (1.18) with dinitrogen as acceptor (1.18.6)
Nitrogenase (1.18.6.1)
Oxidoreductases acting on reduced flavodoxin as donor (1.19)
Oxidoreductases acting on reduced flavodoxin as donor (1.19) with dinitrogen as acceptor (1.19.6)
Nitrogenase (flavodoxin) (1.19.6.1)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Technologies relating to agriculture, livestock or agroalimentary industries
Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
Dinitrogen oxide [N2O], e.g. using aquaponics, hydroponics or efficiency measures
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Dietetic or nutritional methods, e.g. for losing weight
Medicinal preparations containing organic active ingredients
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
Medicinal preparations containing organic active ingredients
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic orhydroximic acids
Carboxylic acids, e.g. valproic acid
Medicinal preparations containing organic active ingredients
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic orhydroximic acids
Carboxylic acids, e.g. valproic acid
Carboxylic acids, e.g. valproic acid having an amino group
Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Proline; Derivatives thereof, e.g. captopril
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
1,3-Diazoles
Imidazole-alkanecarboxylic acids, e.g. histidine
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having saccharide radicals and heterocyclic rings
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Drugs for disorders of the alimentary tract or the digestive system
Drugs for skeletal disorders
Drugs for disorders of the nervous system
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Drugs for immunological or allergic disorders
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
Food compositions, function of food ingredients or processes for food or foodstuffs
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
Triazoles; Hydrogenated triazoles
1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Ureas or thioureas containing the groups >NCON< or >NCSN<
Derivatives containing the group >NCON aryl or >NCSNaryl
Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
Heavy metals; Compounds thereof
Copper
Mixtures of one or more fertilisers with additives not having a specially fertilising activity
Biocides or preservatives, e.g. disinfectants, pesticides or herbicides; Pest repellants or attractants
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the alimentary tract or the digestive system
Antidiarrhoeals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Drugs for disorders of the blood or the extracellular fluid
Antioedematous agents; Diuretics
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids the nitrogen atom being doubly bound to the carbon skeleton
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
N-Aryl derivatives thereof
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Drugs for disorders of the alimentary tract or the digestive system
Antidiarrhoeals
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Gasseri
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Nitriles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof containing a OCON< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
Di-thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Ureas or thioureas containing the groups >NCON< or >NCSN<
Ureas or thioureas containing the groups >NCON< or >NCSN< containing >NCON< or >NCSN< groups directly attached to a cycloaliphatic ring
Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazines; Hydrogenated 1,3-diazines
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
Triazoles; Hydrogenated triazoles
1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Aldonic, ketoaldonic or saccharic acids
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Preparation of compounds containing saccharide radicals
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carbonyl group
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Polymeric products of isocyanates or isothiocyanates
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
Polyisocyanates or polyisothiocyanates
Polyisocyanates or polyisothiocyanates cyclic
Polyisocyanates or polyisothiocyanates cyclic aromatic
Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings
Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups
Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups containing only one alkylene bisphenyl group
Polymeric products of isocyanates or isothiocyanates
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
High-molecular-weight compounds
Polycondensates having carboxylic or carbonic ester groups in the main chain
Polycondensates having carboxylic or carbonic ester groups in the main chain containing only aliphatic groups
Polycondensates having carboxylic or carbonic ester groups in the main chain containing only aliphatic groups derived from dicarboxylic acids and dialcohols
Footwear characterised by the material
Footwear characterised by the material
Footwear characterised by the material made of plastics
Soles; Sole-and-heel integral units
Soles; Sole-and-heel integral units characterised by the material
Plastics, rubber or vulcanised fibre
Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, Ometal, CHO, keto, ether, groups, groups, or groups
Saturated compounds containing more than one carboxyl group
Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
Succinic acid esters
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
Tartaric acid esters
Esters of carboxylic acids; Esters of carbonic or haloformic acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, Ometal, CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
Citric acid esters
Polymeric products of isocyanates or isothiocyanates
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
Processes
Manufacture of cellular products
Polymeric products of isocyanates or isothiocyanates
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
High-molecular-weight compounds
Polycondensates having carboxylic or carbonic ester groups in the main chain
Polycondensates having carboxylic or carbonic ester groups in the main chain containing only aliphatic groups
Polycondensates having carboxylic or carbonic ester groups in the main chain containing only aliphatic groups derived from dicarboxylic acids and dialcohols
Polycondensates having carboxylic or carbonic ester groups in the main chain containing only aliphatic groups derived from dicarboxylic acids and dialcohols from dicarboxylic acids and dialcohols in combination with polycarboxylic acids and/or polyhydroxy compounds which are at least trifunctional
Polymeric products of isocyanates or isothiocyanates
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
High-molecular-weight compounds
Polycondensates having carboxylic or carbonic ester groups in the main chain
Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones prepared from a combination of hydroxycarboxylic acids and/or lactones with polycarboxylic acids or ester forming derivatives thereof and polyhydroxy compounds
Polymeric products of isocyanates or isothiocyanates
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
Compounds of groups C08G18/42, C08G18/48, or C08G18/52
Compounds of group C08G18/42
Compounds of group C08G18/42 with compounds of group C08G18/32 or polyamines of C08G18/38
Compounds of group C08G18/42 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3203
Polymeric products of isocyanates or isothiocyanates
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
Polyisocyanates or polyisothiocyanates
Polyisocyanates or polyisothiocyanates cyclic
Polyisocyanates or polyisothiocyanates cyclic aromatic
Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings
Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
Dicarboxylic acids and dihydroxy compounds
Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
Dicarboxylic acids and dihydroxy compounds
Polyesters having been prepared in the presence of compounds having one reactive group or more than two reactive groups
Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from the reaction of a mixture of hydroxy carboxylic acids, polycarboxylic acids and polyhydroxy compounds
Coating compositions based on polyureas or polyurethanes; Coating compositions based on derivatives of such polymers
Polyurethanes
Polyurethanes from polyesters
Adhesives based on polyureas or polyurethanes; Adhesives based on derivatives of such polymers
Polyurethanes
Polyurethanes from polyesters
Foam properties
Foam properties flexible
Soles
Technologies for solid waste management
Bio-organic fraction processing; Production of fertilisers from the organic fraction of waste or refuse
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Cheese; Cheese preparations; Making thereof
Making cheese curd
Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Cereal-derived products; Malt products; Preparation or treatment thereof
Cereal-derived products
Cereal-derived products; Malt products; Preparation or treatment thereof
Cereal-derived products
Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Paracasei
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Disinfection, sterilisation or deodorisation of air
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Pseudomonas
Disinfection, sterilisation or deodorisation of air
Deodorant compositions
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Evaporators; Condensers
Evaporators
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring nitrogenous groups (2.6)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Preparation of nitrogen-containing organic compounds
Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Neurological disorders, e.g. Alzheimer's disease
Medicinal preparations containing organic active ingredients
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Urokinase; Tissue plasminogen activator
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the blood or the extracellular fluid
Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Colony stimulating factors [CSF]
Detection or diagnosis of diseases
Neurological disorders
Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Homoserine O-acetyltransferase (2.3.1.31)
Acyltransferases (2.3)
Acyl groups converted into alkyl on transfer (2.3.3)
Citrate (Si)-synthase (2.3.3.1)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Homoserine kinase (2.7.1.39)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Phosphoenolpyruvate carboxylase (4.1.1.31)
Genetically modified cells
Cells for production
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring one-carbon groups (2.1)
Carboxy- and carbamoyl transferases (2.1.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring nitrogenous groups (2.6)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with a carboxyl group as acceptor (2.7.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Preparation of nitrogen-containing organic compounds
Amines; Imines
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
N-Acetyl-gamma-glutamyl-phosphate reductase (1.2.1.38)
Transferases transferring one-carbon groups (2.1)
Carboxy- and carbamoyltransferases (2.1.3)
Ornithine carbamoyltransferase (2.1.3.3)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Glutamate N-acetyltransferase (2.3.1.35)
Transferases transferring nitrogenous groups (2.6)
Transaminases (2.6.1)
Acetylornithine transaminase (2.6.1.11)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with a carboxy group as acceptor (2.7.2)
Acetylglutamate kinase (2.7.2.8)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Benzoylformate decarboxylase (4.1.1.7)
Production
Biochemical production, i.e. in a transformed host cell
Specific components of cell culture medium
Organic components
Amines, e.g. putrescine
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
Drugs for genital or sexual disorders; Contraceptives
Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
Antimicrobial preparations
Preparations for care of the skin
Washing or bathing preparations
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Oral administration
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Amines; Imines
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Ornithine decarboxylase (4.1.1.17)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Soil-conditioning materials or soil-stabilising materials
Soil-conditioning materials or soil-stabilising materials containing organic compounds only
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Soil-conditioning materials or soil-stabilising materials
Soil-conditioning materials or soil-stabilising materials containing organic compounds only
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Homoserine O-succinyltransferase (2.3.1.46)
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Use of yeasts or fungi
Nature of the contaminant
Inorganic compounds
Heavy metals or heavy metal compounds
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Homoserine O-succinyltransferase (2.3.1.46)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Leguminosae or Fabaceae, e.g. soybean, alfalfa or peanut
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Fruits
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Euphorbiaceae, e.g. Poinsettia
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Serratia
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Processes using, or culture media containing, hydrocarbons
Processes using, or culture media containing, hydrocarbons aliphatic
Processes using, or culture media containing, hydrocarbons aliphatic having five or less carbon atoms
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing N- glycosyl compounds (3.2.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2) hydrolysing N-glycosyl compounds (3.2.2)
AMP nucleosidase (3.2.2.4)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
Adenosine deaminase (3.5.4.4)
Botany in general
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Superphosphates, i.e. fertilisers produced by reacting rock or bone phosphates with sulfuric or phosphoric acid in such amounts and concentrations as to yield solid products directly
Superphosphates
Preparation of fertilisers characterised by biological or biochemical treatment steps, e.g. composting or fermentation
Mixtures of one or more fertilisers with additives not having a specially fertilising activity
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Technologies for solid waste management
Bio-organic fraction processing; Production of fertilisers from the organic fraction of waste or refuse
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Ureas or thioureas containing the groups >NCON< or >NCSN<
Derivatives containing the group >NCON aryl or >NCSNaryl
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
Preparation of other alcoholic beverages
Preparation of other alcoholic beverages by fermentation
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
Pyridoxal phosphatase (3.1.3.74)
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Lactic or propionic acid bacteria
Lactobacillus
Casei
Preparation of nitrogen-containing organic compounds
Amines; Imines
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Nucleotidyltransferases (2.7.7)
DNA-directed RNA polymerase (2.7.7.6)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Transferases transferring phosphorus-containing groups (2.7)
Nucleotidyltransferases (2.7.7)
DNA-directed RNA polymerase (2.7.7.6)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Phosphoglycerate dehydrogenase (1.1.1.95)
Transferases transferring nitrogenous groups (2.6)
Transaminases (2.6.1)
Phosphoserine transaminase (2.6.1.52)
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
Phosphoserine phosphatase (3.1.3.3)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Animals; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Paenibacillus
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Linear peptides containing only normal peptide links
Linear peptides containing only normal peptide links having 5 to 11 amino acids
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Cyclic peptides containing at least one abnormal peptide link
Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Cyclic peptides containing only normal peptide links
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Enterobacteriales, e.g. Enterobacter
Salmonella
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Salmonella (G)
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Veterinary vaccine
Bacteriophages
Details
Details dsDNA Bacteriophages
Siphoviridae
Methods of production or purification of viral material
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Preparation of nitrogen-containing organic compounds
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Corynebacterium
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
General methods for enhancing the expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Racemaces and epimerases (5.1)
Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
Other enzymes
Milk preparations; Milk powder or milk powder preparations
Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
Preservation of milk or milk preparations
Preservation of milk or milk preparations by heating
Preservation of milk or milk preparations by heating the materials being loose unpacked
Preservation of milk or milk preparations
Preservation of milk or milk preparations by freezing or cooling
Milk preparations; Milk powder or milk powder preparations
Milk preparations; Milk powder or milk powder preparations containing additives
Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Phosphatidylcholine-sterol O-acyltransferase (2.3.1.43), i.e. lecithin-cholesterol acyltransferase or LCAT
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Animal cells
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Medicinal preparations containing antigens or antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Periodont
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
Preservation of milk or milk preparations
Whey; Whey preparations
Whey; Whey preparations
Whey; Whey preparations containing, or treated with, microorganisms or enzymes
Whey; Whey preparations
Whey; Whey preparations containing, or treated with, microorganisms or enzymes
Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
Preservation of milk or milk preparations
Preservation of milk or milk preparations by heating
Preservation of milk or milk preparations by heating the materials being loose unpacked
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Culture media for cell or tissue culture
Preparation of compounds containing saccharide radicals
Monosaccharides
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate
Particular aspects or types of dairy products
Concentrated yoghurt products, e.g. labneh, yoghurt cheese, non-dried non-frozen solid or semi-solid yoghurt products other than spreads; Strained yoghurt; Removal of whey from yoghurt
Lactic or propionic acid bacteria
Lactobacillus
Bulgaricus
Lactic or propionic acid bacteria
Streptococcus, lactococcus
Thermophilus
Specific components of cell culture medium
Undefined extracts
Undefined extracts from animals
Undefined extracts from animals from mammals
Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
New or modified breeds of vertebrates
Genetically modified vertebrates, e.g. transgenic
Knock-in vertebrates, e.g. humanised vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Immunoglobulin superfamily
MHC-molecules, e.g. HLA-molecules
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Embryonic cells ; Embryoid bodies
Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Hepatocytes
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Hepatocytes
Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
Genetically modified animals
Animals genetically altered by homologous recombination
Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
Animals characterised by species
Mammal
Murine
Animals characterised by purpose
Animal zootechnically ameliorated
Animals characterised by purpose
Animal model, e.g. for test or diseases
Active agents used in cell culture processes, e.g. differentation
Growth factors
Basic fibroblast growth factor (bFGF, FGF-2)
Active agents used in cell culture processes, e.g. differentation
Growth factors
Hepatocyte growth factor [HGF]
Active agents used in cell culture processes, e.g. differentation
Growth factors
Activin; Inhibin; Mullerian inhibiting substance
Active agents used in cell culture processes, e.g. differentation
Cytokines; Chemokines
Interleukins [IL]
Leukemia inhibitory factor [LIF]
Active agents used in cell culture processes, e.g. differentation
Cytokines; Chemokines
Oncostatin M [OSM]
Active agents used in cell culture processes, e.g. differentation
Hormones
Hormones with nuclear receptors
Steroid hormones
Active agents used in cell culture processes, e.g. differentation
Enzymes
Transferases (EC 2.)
Kinases (EC 2.7.)
Active agents used in cell culture processes, e.g. differentation
Proteins not provided for elsewhere
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Genetically modified cells
Cells related to new breeds of animals
Cells from transgenic animals
Compounds containing amino and carboxyl groups bound to the same carbon skeleton
Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring one-carbon groups (2.1)
Carboxy- and carbamoyl transferases (2.1.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Amines; Imines
Transferases transferring one-carbon groups (2.1)
Carboxy- and carbamoyltransferases (2.1.3)
Ornithine carbamoyltransferase (2.1.3.3)
Acyltransferases (2.3)
Acyl groups converted into alkyl on transfer (2.3.3)
Citrate (Si)-synthase (2.3.3.1)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Ornithine decarboxylase (4.1.1.17)
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Periodont
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antivirals for DNA viruses for herpes viruses
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
Aspartate-semialdehyde dehydrogenase (1.2.1.11)
Oxidoreductases acting on NADH or NADPH (1.6)
Oxidoreductases acting on NADH or NADPH (1.6) with NAD+ or NADP+ as acceptor (1.6.1)
NAD(P)+ transhydrogenase (B-specific) (1.6.1.1)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Homoserine O-acetyltransferase (2.3.1.31)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Homoserine kinase (2.7.1.39)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of compounds containing saccharide radicals
Monosaccharides
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptococcus ; Enterococcus; Lactococcus
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Other non-alcoholic beverages
Other non-alcoholic beverages fermented
Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
Fermented products; Products treated with microorganisms or enzymes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing inorganic active ingredients
Alkali metal chlorides; Alkaline earth metal chlorides
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Monosaccharides having only carbon, hydrogen and oxygen atoms
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Disaccharides, e.g. lactose, lactulose
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Inorganic compounds
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
Carboxylic acids; Salts or anhydrides thereof
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Cellulose; Derivatives thereof
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Medicinal preparations characterised by special physical form
Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Medicinal preparations characterised by special physical form
Solutions
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Medicinal preparations characterised by special physical form
Pills, tablets, discs, rods
Excipients; Inactive ingredients
Organic compounds, e.g. phospholipids, fats
Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Drugs for genital or sexual disorders; Contraceptives
Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
Lactic or propionic acid bacteria
Lactobacillus
Acidophilus
Lactic or propionic acid bacteria
Lactobacillus
Casei
Lactic or propionic acid bacteria
Lactobacillus
Paracasei
Lactic or propionic acid bacteria
Lactobacillus
Pentosus
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Lactic or propionic acid bacteria
Lactobacillus
Rhamnosus
Lactic or propionic acid bacteria
Bifidobacterium
Adolescentes
Lactic or propionic acid bacteria
Bifidobacterium
Bifidum
Lactic or propionic acid bacteria
Bifidobacterium
Breve
Lactic or propionic acid bacteria
Bifidobacterium
Catenulatum
Lactic or propionic acid bacteria
Bifidobacterium
Infantis
Lactic or propionic acid bacteria
Bifidobacterium
Lactis
Lactic or propionic acid bacteria
Bifidobacterium
Longum
Lactic or propionic acid bacteria
Bifidobacterium
Pseudocatenulatum
Lactic or propionic acid bacteria
Bifidobacterium
Thermacidophilum
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Yeast isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Pichia
Preparation of wine or sparkling wine
Preparation of must from grapes; Must treatment and fermentation
Preparation of must from grapes; Must treatment and fermentation by microbiological or enzymatic treatment
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Botany in general
Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Improving land use; Improving water use or availability; Controlling erosion
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the alimentary tract or the digestive system
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the kidneys
Drugs for dermatological disorders
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Antihyperlipidemics
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Complete heavy chain or Fd fragment, i.e. VH + CH1
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Complete light chain, i.e. VL + CL
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
CH1 domain
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
CH2 domain
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
CH3 domain
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
CH4 domain
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Hinge
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Fab or Fab'
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Framework region [FR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Agonist effect on antigen
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Stability, e.g. half-life, pH, temperature or enzyme-resistance
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Pseudomonas
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Specific bacteria not otherwise provided for
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Medicinal preparations characterised by special physical form
Preparations in capsules, e.g. of gelatin, of chocolate
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Drugs for disorders of the respiratory system
Antiasthmatics
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Promoters of weight control and weight loss
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring aldehyde or ketonic groups (2.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
Trans,polycis-decaprenyl diphosphate synthase (2.5.1.86)
Transferases transferring aldehyde or ketonic groups (2.2)
Transketolases and transaldolases (2.2.1)
1-Deoxy-D-xylulose-5-phosphate synthase (2.2.1.7)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
All-trans-decaprenyl-diphosphate synthase (2.5.1.91)
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Specific bacteria not otherwise provided for
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Medicinal preparations characterised by special physical form
Galenical forms not covered by A61K9/02-A61K9/7023
Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Medicinal preparations characterised by special physical form
Preparations in capsules, e.g. of gelatin, of chocolate
Drugs for disorders of the alimentary tract or the digestive system
Laxatives
Drugs for disorders of the alimentary tract or the digestive system
Antidiarrhoeals
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
Acanthopanax or Eleutherococcus
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Atractylodes
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
Perilla (beefsteak plant)
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Preparation or pretreatment of starting material
Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Extraction of the material
Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Extraction of the material
Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Methods involving additional extraction steps
Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Destroying solid waste or transforming solid waste into something useful or harmless
Destroying solid waste or transforming solid waste into something useful or harmless
Destroying solid waste or transforming solid waste into something useful or harmless involving thermal treatment, e.g. evaporation
Operations not covered by a single other subclass or by a single other group in this subclass
Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
Particles; Beads; Granular material; Encapsulation
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Yeast isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
Enzymes or microbial cells immobilised on or in an organic carrier
Processes involving microorganisms of different genera in the same process, simultaneously
Apparatus and plants for the biological treatment of water, waste water or sewage
Apparatus and plants for the biological treatment of water, waste water or sewage comprising a selector reactor for promoting floc-forming or other bacteria
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Consortia of bacteria
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Use of yeasts or fungi
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Candida
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Docosahexenoic acids [DHA]
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Accessory food factors for animal feeding-stuffs
Organic substances
Amino acids; Derivatives thereof
Polymeric derivatives, e.g. peptides or proteins
Accessory food factors for animal feeding-stuffs
Organic substances
Fatty acids; Fats; Products containing oils or fats
Feeding-stuffs specially adapted for particular animals
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Fatty acids or derivatives thereof; Fats or oils
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Protozoa; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Unicellular algae isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Preparation of peptides or proteins
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Food compositions, function of food ingredients or processes for food or foodstuffs
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Microorganisms ; Processes using microorganisms
Algae ; Processes using algae
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Drugs for disorders of the alimentary tract or the digestive system
Drugs for dermatological disorders
Drugs for immunological or allergic disorders
Antiallergic agents
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Probiotics, living bacteria to be ingested for action in the digestive tract
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Bacillus
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Vibrio
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Nature of the contaminant
Inorganic compounds
Phosphorus compounds
Nature of the contaminant
Inorganic compounds
Nitrogen compounds, e.g. ammonia
Nature of the contaminant
Inorganic compounds
Nitrogen compounds, e.g. ammonia
Nitrites
Nature of the water, waste water, sewage or sludge to be treated
Contaminated open waterways, rivers, lakes or ponds
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Ortho-condensed systems
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
1,4-Benzodiazepines, e.g. diazepam or clozapine
1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Lactic or propionic acid bacteria
Lactobacillus
Bulgaricus
Lactic or propionic acid bacteria
Streptococcus, lactococcus
Thermophilus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Oxidoreductases (1)
Superoxide dismutase (1.15)
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Accessory food factors for animal feeding-stuffs
Organic substances
Amino acids; Derivatives thereof
Accessory food factors for animal feeding-stuffs
Organic substances
Antibiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Peptides; Protein hydrolysates
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Proteins; Peptides; Derivatives or degradation products thereof
Preparations for care of the skin
Preparations for oily skin
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Oxidoreductases acting on superoxide as acceptor (1.15)
Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
Superoxide dismutase (1.15.1.1)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring nitrogenous groups (2.6)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Bacteria
Chemistry: molecular biology and microbiology
Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
Chemistry: molecular biology and microbiology
Test strip or test slide
Chemistry: molecular biology and microbiology
Kit
Chemistry: analytical and immunological testing
Apparatus included in process claim, e.g. physical support structures
Automated or kit
Chemistry: analytical and immunological testing
Apparatus included in process claim, e.g. physical support structures
Tube, bottle, or dipstick
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Xylanases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,4-beta-xylanase (3.2.1.8)
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Igs containing Ig-regions, -domains or -residues form different species
Igs containing CDR-residues from one specie grafted between FR-residues from another
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Medicinal preparations containing peptides
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Fusion polypeptide
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Medicinal preparations containing peptides
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Fusion polypeptide
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Regulators; Modulating activity
Inhibitors; Suppressors
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Medicinal preparations containing peptides
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Igs containing Ig-regions, -domains or -residues form different species
Igs with modifications in the FR-residues only
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for controlling, regulating or enhancing expression of transgenes in plant cells
Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
Reproductive tissue-specific promoters
Seed-specific, e.g. embryo, endosperm
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Fusion polypeptide
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Carbocyclic rings
Condensed ring systems having three or more rings
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Preparation of compounds containing saccharide radicals
Preparation of O-glycosides, e.g. glucosides
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
Ortho-condensed systems
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Carbocyclic rings
Condensed ring systems having three or more rings
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Preparation of compounds containing saccharide radicals
Preparation of O-glycosides, e.g. glucosides
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving proteins of known structure or function as defined in the subgroups
Details
Lipocortins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with yeasts
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds
Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds the radical having only two carbon-to-carbon double bonds
Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, at least one having two or more carbon-to-carbon double bonds the radical having only two carbon-to-carbon double bonds conjugated
Isoprene
Fusion polypeptide
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Vibrio
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Medicinal preparations containing organic active ingredients
Amides, e.g. hydroxamic acids
Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Peptides; Protein hydrolysates
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for dermatological disorders
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Food ingredients
Proteins
Animal Protein
Collagen
Lactic or propionic acid bacteria
Lactobacillus
Delbrueckii
Lactic or propionic acid bacteria
Streptococcus, lactococcus
Thermophilus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptococcus ; Enterococcus; Lactococcus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Screening for compounds of potential therapeutic value
Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Detection or diagnosis of diseases
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Mannanases
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Mannokinase (2.7.1.7)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Sucrose alpha-glucosidase (3.2.1.48), i.e. sucrase
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having three or more nucleosides or nucleotides
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having three or more nucleosides or nucleotides
Double-stranded nucleic acids or oligonucleotides
Medicinal preparations containing antigens or antibodies
Vertebrate antigens
Medicinal preparations containing antigens or antibodies
Vertebrate antigens
Nervous system antigens; Prions
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
Drugs for disorders of the muscular or neuromuscular system
Muscle relaxants, e.g. for tetanus or cramps
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for peripheral neuropathies
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Anti-Parkinson drugs
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Neurological disorders, e.g. Alzheimer's disease
Animals characterised by purpose
Animal model, e.g. for test or diseases
Animal model for genetic diseases
Animal model for Alzheimer's disease
Animals characterised by purpose
Animal model, e.g. for test or diseases
Animal model for genetic diseases
Animal model for neurodegenerative disease, e.g. non- Alzheimer's
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
DNA (RNA) vaccination
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Assays involving biological materials from specific organisms or of a specific nature
Enzymes; Proenzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on superoxide radicals as acceptor (1.15)
Detection or diagnosis of diseases
Neurological disorders
Dementia; Cognitive disorders
Prion diseases
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Casein
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Peptides; Protein hydrolysates
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Dairy proteins
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Linear peptides containing only normal peptide links
Linear peptides containing only normal peptide links having 5 to 11 amino acids
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Linear peptides containing only normal peptide links
Linear peptides containing only normal peptide links having 12 to 20 amino acids
Preparation of peptides or proteins
Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Medicinal preparations containing peptides
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleosides
Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carbonyl group
Ketones
Acetone-containing products
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
2-Hydroxy-3-oxopropionate reductase (1.1.1.60)
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Hydroxypyruvate reductase (1.1.1.81)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Tartronate-semialdehyde synthase (4.1.1.47)
Carbon-carbon lyases (4.1)
Oxo-acid-lyases (4.1.3)
Malyl-CoA lyase (4.1.3.24)
Ligases forming carbon-sulfur bonds (6.2)
Acid-Thiol Ligases (6.2.1)
Malate--CoA ligase (6.2.1.9)
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of colon
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of lung
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of stomach or intestine
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
Interleukin
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Hinge
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Oligonucleotides characterized by their use
Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Oligonucleotides characterized by their use
Expression markers
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving growth factors
Transforming growth factor [TGF]
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving cytokines
Interleukins [IL]
IL-8
Assays involving biological materials from specific organisms or of a specific nature
Enzymes; Proenzymes
Isomerases (5.)
Detection or diagnosis of diseases
Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Blood coagulation or fibrinolysis factors
Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Drugs for disorders of the blood or the extracellular fluid
Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
Serine endopeptidases (3.4.21)
Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
Medicinal preparations containing peptides
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Oxidoreductases acting on other nitrogenous compounds as donors (1.7)
Oxidoreductases acting on other nitrogenous compounds as donors (1.7) with oxygen as acceptor (1.7.3)
Factor-independent urate hydroxylase (1.7.3.3), i.e. uricase
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Oxidoreductases (1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
Uricase (1.7.3.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
Serine endopeptidases (3.4.21)
Coagulation factor VIIa (3.4.21.21)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Blood coagulation or fibrinolysis factors
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
Dihydrofolate reductase [DHFR] (1.5.1.3)
Preparation of peptides or proteins
Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Oxidoreductases acting on the CH-NH group of donors (1.5)
Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
Dihydrofolate reductase (1.5.1.3)
Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
Serine endopeptidases (3.4.21)
Coagulation factor VIIa (3.4.21.21)
Use of organic ingredients
Oxygen-containing compounds
Alcohols; Metal alcoholates
Polyhydroxylic alcohols
Processes of treating or compounding macromolecular substances
Compounding polymers with additives, e.g. colouring
Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
Manufacture of articles or shaped materials containing macromolecular substances
Manufacture of films or sheets
Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
Polyesters derived from hydroxy carboxylic acids, e.g. lactones
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Bifidobacterium
Longum
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
1,3-Thiazoles; Hydrogenated 1,3-thiazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having saccharide radicals and heterocyclic rings
Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
3,4-Dihydrobenzopyrans, e.g. chroman, catechin
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Sugars; Derivatives thereof
Glycosides, e.g. rutin
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Angiosperms [Magnoliophyta]
Magnoliopsida [dicotyledons]
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Skin, i.e. galenical aspects of topical compositions
Drugs for dermatological disorders
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Preparations for care of the skin
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Stems
Processes for modifying genotypes ; Plants characterised by associated natural traits
Processes of selection involving genotypic or phenotypic markers; Methods of using phenotypic markers for selection
Processes of selection involving genotypic or phenotypic markers; Methods of using phenotypic markers for selection using molecular markers
Processes for modifying genotypes ; Plants characterised by associated natural traits
Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits
Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine or caffeine
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Amaryllidaceae, e.g. onion
Allium cepa [onion]
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid amplification reactions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Carbon-sulfur lyases (4.4)
Carbon-sulfur lyases (4.4.1)
Alliin lyase (4.4.1.4)
Oligonucleotides characterized by their use
Plant traits
Oligonucleotides characterized by their use
Polymorphic or mutational markers
Oligonucleotides characterized by their use
Primer sets for multiplex assays
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
(2E,6E)-Farnesyl diphosphate synthase (2.5.1.10), i.e. geranyltranstransferase
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
Geranylgeranyl diphosphate synthase (2.5.1.29)
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Oligonucleotides characterized by their use
Polymorphic or mutational markers
Medicinal preparations containing antigens or antibodies
Vertebrate antigens
Cancer antigens
Antineoplastic agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Animal cells
Tumor cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Animal cells
Animal cells expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Organic adjuvants
Cytokines; Lymphokines; Interferons
Interleukins
Medicinal preparations containing antigens or antibodies
Vaccine for a specifically defined cancer
Skin, melanoma
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Milk; Whey; Colostrum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
Milk; Derivatives thereof, e.g. butter
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Drugs for dermatological disorders
Preparations for care of the skin
Preparations for care of the skin
Anti-ageing preparations
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Tea; Tea substitutes; Preparations thereof
Tea extraction; Tea extracts; Treating tea extract; Making instant tea
Addition of, or treatment with, enzymes or microorganisms
Tea; Tea substitutes; Preparations thereof
Tea substitutes, e.g. mat; Extracts or infusions thereof
Coffee; Coffee substitutes; Preparations thereof
Extraction of coffee; Coffee extracts; Making instant coffee
Addition of, or treatment with, enzymes or microorganisms
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the respiratory system
Nasal agents, e.g. decongestants
Drugs for disorders of the respiratory system
Antiasthmatics
Drugs for dermatological disorders
Drugs for dermatological disorders
Antipruritics
Drugs for disorders of the senses
Ophthalmic agents
Drugs for disorders of the senses
Ophthalmic agents
Decongestants or antiallergics
Drugs for disorders of the senses
Otologicals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antineoplastic agents
Drugs for immunological or allergic disorders
Antiallergic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Drugs for disorders of the alimentary tract or the digestive system
Laxatives
Drugs for disorders of the alimentary tract or the digestive system
Antidiarrhoeals
Drugs for disorders of the respiratory system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for influenza or rhinoviruses
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin the drug being a peptidic cytokine, e.g. an interleukin or interferon
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Drugs for genital or sexual disorders; Contraceptives
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Antineoplastic agents
Drugs for immunological or allergic disorders
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the endocrine system
Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Drugs for disorders of the endocrine system
Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Drugs for disorders of the blood or the extracellular fluid
Drugs for disorders of the blood or the extracellular fluid
Antianaemics
Drugs for disorders of the cardiovascular system
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Erythropoietin [EPO]
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Colony-stimulating factor [CSF]
Granulocyte CSF; Granulocyte-macrophage CSF
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interferons [IFN]
IFN-alpha
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Hormones
Growth hormone [GH], i.e. somatotropin
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Complement-dependent cytotoxicity [CDC]
Fusion polypeptide
Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Viruses, e.g. bacteriophages
Accessory food factors for animal feeding-stuffs
Accessory food factors for animal feeding-stuffs
Organic substances
Accessory food factors for animal feeding-stuffs
Organic substances
Amino acids; Derivatives thereof
Polymeric derivatives, e.g. peptides or proteins
Accessory food factors for animal feeding-stuffs
Organic substances
Antibiotics
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for ruminants
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Viruses; Subviral particles; Bacteriophages
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteriophages
Details
Details dsDNA Bacteriophages
Siphoviridae
Viruses as such, e.g. new isolates, mutants or their genomic sequences
Bacteriophages
Details
Details dsDNA Bacteriophages
Siphoviridae
Uses of virus other than therapeutic or vaccine, e.g. disinfectant
Bacteriophages
Details
Details dsDNA Bacteriophages
Siphoviridae
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Salmonella
Microorganisms ; Processes using microorganisms
Cell lines ; Processes using cell lines
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on beta-1,4-glucosidic bonds
Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
Preparation of compounds containing saccharide radicals
Monosaccharides
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Pentosyltransferases (2.4.2)
Glycosyltransferases (2.4)
Pentosyltransferases (2.4.2)
Anthranilate phosphoribosyltransferase (2.4.2.18)
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Preparation of other alcoholic beverages
Preparation of other alcoholic beverages by fermentation
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Digestive system
Liver; Hepatocytes
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism
Antihyperlipidemics
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antibacterial agents for leprosy
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the blood or the extracellular fluid
Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Hepatocytes
Stem cells; Progenitor cells; Precursor cells; Oval cells
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
Liver cells
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring aldehyde or ketonic groups (2.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with a carboxyl group as acceptor (2.7.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Transferases transferring aldehyde or ketonic groups (2.2)
Transketolases and transaldolases (2.2.1)
Transketolase (2.2.1.1)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with a carboxy group as acceptor (2.7.2)
Aspartate kinase (2.7.2.4)
Ligases forming carbon-carbon bonds (6.4)
Ligases forming carbon-carbon bonds (6.4.1)
Pyruvate carboxylase (6.4.1.1)
Nucleic acids vectors
Plasmid DNA
Plasmid DNA for bacteria
Nucleic acids vectors
Vectors comprising a coding region that has been codon optimised for expression in a respective host
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
O-Aryl or S-Aryl esters thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof containing the groups, or; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring aldehyde or ketonic groups (2.2)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Transferases transferring aldehyde or ketonic groups (2.2)
Transketolases and transaldolases (2.2.1)
Acetolactate synthase (2.2.1.6)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the respiratory system
Drugs for disorders of the respiratory system
Nasal agents, e.g. decongestants
Drugs for disorders of the respiratory system
Antiasthmatics
Drugs for dermatological disorders
Drugs for dermatological disorders
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Drugs for dermatological disorders
Antipsoriatics
Drugs for skeletal disorders
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Drugs for disorders of the senses
Ophthalmic agents
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for immunological or allergic disorders
Antiallergic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the blood or the extracellular fluid
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Drugs for disorders of the cardiovascular system
Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the respiratory system
Drugs for disorders of the respiratory system
Nasal agents, e.g. decongestants
Drugs for disorders of the respiratory system
Antiasthmatics
Drugs for disorders of the respiratory system
Central respiratory analeptics
Drugs for dermatological disorders
Drugs for dermatological disorders
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Drugs for dermatological disorders
Antipsoriatics
Drugs for skeletal disorders
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Drugs for disorders of the senses
Ophthalmic agents
Drugs for disorders of the senses
Ophthalmic agents
Decongestants or antiallergics
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antineoplastic agents
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for immunological or allergic disorders
Antiallergic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Drugs for disorders of the cardiovascular system
Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interleukins [IL]
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Medicinal preparations containing peptides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Symbiotic or parasitic combinations including one or more new plants, e.g. mycorrhiza
Fungi; Lichens
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing halogenated hydrocarbons
Halogen attached to an aliphatic side chain of an aromatic ring system
1,1-Di- or 1,1,1-trihalo-2-aryl-ethane or -ethene or derivatives thereof, e.g. DDT
Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
Oxygen or sulfur directly attached to an aromatic ring system
Ethers
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Ureas or thioureas containing the groups >NCON< or >NCSN<
Ureas or thioureas containing the groups >NCON< or >NCSN< containing the groups, e.g. biuret; Thio analogues thereof; Urea-aldehyde condensation products
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Ureas or thioureas containing the groups >NCON< or >NCSN<
Ureas or thioureas containing the groups >NCON< or >NCSN< containing the group >NCON< where at least one nitrogen atom is part of a heterocyclic ring; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing organic active ingredients
Phosphorus compounds
Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Rectum, anus
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Medicinal preparations characterised by special physical form
Preparations in capsules, e.g. of gelatin, of chocolate
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Anti-Parkinson drugs
Drugs for disorders of the nervous system
Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Drugs for disorders of the nervous system
Anxiolytics
Drugs for disorders of the nervous system
Antidepressants
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the nervous system
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Blood; Artificial blood
Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the respiratory system
Antiasthmatics
Drugs for dermatological disorders
Antipsoriatics
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Antineoplastic agents
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Specific bacteria not otherwise provided for
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Rectum, anus
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Nose
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Anti-Parkinson drugs
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring aldehyde or ketonic groups (2.2)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Transferases transferring aldehyde or ketonic groups (2.2)
Transketolases and transaldolases (2.2.1)
Acetolactate synthase (2.2.1.6)
Carbon-carbon lyases (4.1)
Oxo-acid-lyases (4.1.3)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Plant growth regulators
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Mixtures of one or more fertilisers with additives not having a specially fertilising activity
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Processes using, or culture media containing, lower alkanols, i.e. C1 to C6
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Technologies for the production of fuel of non-fossil origin
Fuel from waste, e.g. synthetic alcohol or diesel
Technologies relating to agriculture, livestock or agroalimentary industries
Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
Dinitrogen oxide [N2O], e.g. using aquaponics, hydroponics or efficiency measures
Technologies for solid waste management
Bio-organic fraction processing; Production of fertilisers from the organic fraction of waste or refuse
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing organic active ingredients
Amines
Amines having aromatic rings, e.g. ketamine, nortriptyline
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
Medicinal preparations containing organic active ingredients
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic orhydroximic acids
Carboxylic acids, e.g. valproic acid
Carboxylic acids, e.g. valproic acid having an amino group
Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
Medicinal preparations containing organic active ingredients
Esters, e.g. nitroglycerine, selenocyanates
Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
1,3-Diazoles
1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Non condensed pyridines; Hydrogenated derivatives thereof
Non condensed piperidines, e.g. piperocaine
Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having saccharide radicals and heterocyclic rings
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from lung cancer cell
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
Polysaccharides
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Algae
Preparations for care of the skin
Anti-ageing preparations
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Unicellular algae isolates
Microorganisms ; Processes using microorganisms
Algae ; Processes using algae
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Viruses; Subviral particles; Bacteriophages
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Polyvalent viral antigens; Mixtures of viral and bacterial antigens
Drugs for disorders of the cardiovascular system
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Recovery or purification
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Inactivation or attenuation; Producing viral sub-units
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Inactivation or attenuation; Producing viral sub-units
Inactivation or attenuation by chemical treatment
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Viruses as such, e.g. new isolates, mutants or their genomic sequences
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from viruses
RNA viruses
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Protozoa; Culture media therefor
Accessory food factors for animal feeding-stuffs
Organic substances
Fatty acids; Fats; Products containing oils or fats
Accessory food factors for animal feeding-stuffs
Organic substances
Colouring agents, e.g. pigmenting or dyeing agents
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Fatty acids or derivatives thereof; Fats or oils
Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
Colouring or decolouring of foods
Addition of dyes or pigments, e.g. in combination with optical brighteners
Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
General protective or antinoxious agents
Free radical scavengers or antioxidants
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Unicellular algae isolates
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Eicosapentaenoic acids [EPA]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Docosahexenoic acids [DHA]
Microorganisms ; Processes using microorganisms
Algae ; Processes using algae
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
Drugs for genital or sexual disorders; Contraceptives
Drugs for skeletal disorders
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Antiparasitic agents
Ectoparasiticides, e.g. scabicides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Uses of viruses
Uses of viruses as vector
Uses of viruses as vector for the expression of a heterologous nucleic acid
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Antiparasitic agents
Anthelmintics
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Receptors; Cell surface antigens; Cell surface determinants for hormones
G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Supracellular entities, e.g. tissue, organisms
Supracellular entities, e.g. tissue, organisms of invertebrates
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Intracellular protein regulatory factors and their receptors, e.g. including ion channels
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving proteins of known structure or function as defined in the subgroups
Details
G-proteins
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Carbocyclic rings
Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Compounds containing amino and hydroxy groups bound to the same carbon skeleton
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and acyclic
Compounds containing amino groups and doublybound oxygen atoms bound to the same carbon skeleton, at least one of the doublybound oxygen atoms not being part of a CHO group, e.g. amino ketones
Compounds containing amino groups and doublybound oxygen atoms bound to the same carbon skeleton, at least one of the doublybound oxygen atoms not being part of a CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
Compounds containing amino groups and doublybound oxygen atoms bound to the same carbon skeleton, at least one of the doublybound oxygen atoms not being part of a CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
Esters of sulfuric acids
Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and unsaturated
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Acyclic radicals, not substituted by cyclic structures
Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Acyclic radicals, substituted by carbocyclic rings
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Acyclic or carbocyclic radicals, substituted by hetero rings
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of sulfur-containing organic compounds
Preparation of nitrogen-containing organic compounds
Amines; Imines
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Preparation of compounds containing saccharide radicals
Preparation of O-glycosides, e.g. glucosides
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Systems containing only non-condensed rings
Systems containing only non-condensed rings with a five-membered ring
Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
Systems containing only non-condensed rings
Systems containing only non-condensed rings with a six-membered ring
The ring being saturated
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against prion molecules, e.g. CD230
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Hypnotics; Sedatives
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Skin, nerves, brain
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Neurological disorders, e.g. Alzheimer's disease
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Organic adjuvants
Emulsions, e.g. Freund's adjuvant, MF59
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
Proteins
Albumin; Keyhole limpet haemocyanin [KLH]
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Uses of viruses
Uses of viruses as vector
Uses of viruses as vector for the expression of a heterologous nucleic acid
Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Detection or diagnosis of diseases
Neurological disorders
Dementia; Cognitive disorders
Prion diseases
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
Medicinal preparations containing peptides
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Quinolines; Isoquinolines forming part of bridged ring systems
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Pulmonary tract; Aromatherapy
Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
Medicinal preparations characterised by special physical form
Dispersions; Emulsions
Liposomes
Drugs for disorders of the respiratory system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antibacterial agents for tuberculosis
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazines; Hydrogenated 1,3-diazines
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleosides
Pyrimidine nucleosides
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazines; Hydrogenated 1,3-diazines
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group CON<, e.g. carboxylic acid amides or imides; Thio analogues thereof the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings condensed with a carbocyclic ring
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazoles; Hydrogenated 1,3-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazines; Hydrogenated 1,3-diazines
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
1,3-Thiazoles; Hydrogenated 1,3-thiazoles
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof containing a OCON< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
Di-thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
O-Aryl or S-Aryl esters thereof
Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazines; Hydrogenated 1,3-diazines
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus subtilis ; Hay bacillus; Grass bacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
Removal of unwanted matter, e.g. deodorisation or detoxification
Removal of unwanted matter, e.g. deodorisation or detoxification using microorganisms
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with yeasts
Coffee; Coffee substitutes; Preparations thereof
Treating green coffee; Preparations produced thereby
Products from fruits or vegetables; Preparation or treatment thereof
Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops of potatoes
Products from fruits or vegetables; Preparation or treatment thereof
Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops of potatoes
Roasted or fried products, e.g. snacks or chips
Products from fruits or vegetables; Preparation or treatment thereof
Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops of potatoes
Roasted or fried products, e.g. snacks or chips
Roasted or fried products, e.g. snacks or chips from powdered or mashed potato products
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Yeasts or derivatives thereof
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Adaptation or attenuation of cells
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Asparaginase (3.5.1.1)
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Culture media therefor
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Enterobacteriales, e.g. Enterobacter
Salmonella
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Inorganic compounds
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
Carboxylic acids; Salts or anhydrides thereof
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
Proteins
Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Medicinal preparations containing antigens or antibodies
Multivalent vaccine
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Skin, i.e. galenical aspects of topical compositions
Drugs for genital or sexual disorders; Contraceptives
Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
Drugs for dermatological disorders
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Lysis of microorganisms
Lysis of microorganisms by physical methods
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from microorganisms
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Stable introduction of foreign DNA into chromosome
Stable introduction of foreign DNA into chromosome using homologous recombination
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Glycosaminoglycans, i.e. mucopolysaccharides
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations characterised by special physical form
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Drugs for dermatological disorders
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Drugs for immunological or allergic disorders
Immunomodulators
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Preparation of steroids
Hydroxylating
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antineoplastic agents
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
[b, e]- or [b, f]-condensed with six-membered rings
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Medicinal preparations containing peptides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Micromonospora
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Oligonucleotides characterized by their use
Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Oligonucleotides characterized by their use
Screening for pharmacological compounds
Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Eicosapentaenoic acids [EPA]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Docosahexenoic acids [DHA]
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Preparation of nitrogen-containing organic compounds
Preparation of nitrogen-containing organic compounds containing a N-O bond, e.g. nitro (-NO2), nitroso (-NO)
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Carbonyl reductase (NADPH) (1.1.1.184)
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Glucose 1-dehydrogenase (1.1.1.47)
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds characterised by the fatty product used, e.g. fat, fatty acid, fatty alcohol, their esters, lecithin, glycerides
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
Sulfonic acids; Derivatives thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin comprising polyesters
Layered products characterised by the relation between layers; Layered products characterised by the relative orientation of features between layers, or by the relative values of a measurable parameter between layers, i.e. products comprising layers having different physical, chemical or physicochemical properties; Layered products characterised by the interconnection of layers
Interconnection of layers
Interconnection of layers at least one layer having inter-reactive properties
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Combinations of extrusion moulding with other shaping operations
Combinations of extrusion moulding with other shaping operations combined with cutting
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the choice of material
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
Particle-shaped
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
Filamentary, e.g. strands
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Articles comprising two or more components, e.g. co-extruded layers
Articles comprising two or more components, e.g. co-extruded layers the components being layers
Articles comprising two or more components, e.g. co-extruded layers the components being layers the layers being joined at their surfaces
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Component parts, details or accessories; Auxiliary operations
Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die
Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die using screws surrounded by a cooperating barrel, e.g. single screw extruders
Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die using screws surrounded by a cooperating barrel, e.g. single screw extruders using two or more parallel screws or at least two parallel non-intermeshing screws, e.g. twin screw extruders
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Component parts, details or accessories; Auxiliary operations
Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die
Details of extruders
Screws
Screws characterised by the ratio of the threaded length of the screw to its outside diameter [L/D ratio]
Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Component parts, details or accessories; Auxiliary operations
Measuring, controlling or regulating
Layered products having a non-planar shape
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin characterised by the use of special additives
Layered products comprising a layer of synthetic resin characterised by the use of special additives using fillers, pigments, thixotroping agents
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers
Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers comprising aromatic vinyl (co)polymers, e.g. styrenic (co)polymers
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers
Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers comprising vinyl acetate or vinyl alcohol (co)polymers
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers
Layered products comprising a layer of synthetic resin comprising vinyl (co)polymers; comprising acrylic (co)polymers comprising acrylic (co)polymers
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin comprising polyolefins
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin comprising polyamides
Layered products comprising a layer of synthetic resin
Layered products comprising a layer of synthetic resin comprising polyesters
Layered products comprising a layer of synthetic resin comprising polyesters comprising polycarbonates
Layered products characterised by the relation between layers; Layered products characterised by the relative orientation of features between layers, or by the relative values of a measurable parameter between layers, i.e. products comprising layers having different physical, chemical or physicochemical properties; Layered products characterised by the interconnection of layers
Interconnection of layers
Interconnection of layers using interposed adhesives or interposed materials with bonding properties
Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
Polymers modified by chemical after-treatment
Polymers modified by chemical after-treatment derived from polycarboxylic acids and polyhydroxy compounds
Dicarboxylic acids and dihydroxy compounds
Compositions of unspecified macromolecular compounds
Compositions of unspecified macromolecular compounds the macromolecular compounds being biodegradable
Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
Polyesters derived from dicarboxylic acids and dihydroxy compounds
Indexing scheme relating to extrusion moulding
Measuring, controlling or regulating
Controlled parameter
Velocity
Angular velocity
Indexing scheme relating to extrusion moulding
Measuring, controlling or regulating
Controlled parameter
Temperature
Layers arrangement
2 layers
Layers arrangement
3 layers
Layers arrangement
4 layers
Layers arrangement
5 or more layers
Layers arrangement
All layers being polymeric
Layers arrangement
Symmetrical or sandwich layers, e.g. ABA, ABCBA, ABCCBA
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Glass
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Oxide or hydroxide
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Oxide or hydroxide
Silica
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Oxide or hydroxide
Alumina
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Oxide or hydroxide
Mica
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Oxide or hydroxide
Clay
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Oxysalt, e.g. carbonate, sulfate, phosphate or nitrate particles
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Metal
Composition or properties of particles which form a particulate layer or are present as additives
Inorganic particles
Ceramic
Carbon, e.g. graphite particles
Resin or rubber layer containing a blend of at least two different polymers
Properties of the layers or laminate
Properties of the layers or laminate having particular thermal properties
Heat sealable
Properties of the layers or laminate
Other properties
Degradable
Biodegradable
Properties of the layers or laminate
Other properties
Permeability to gases, adsorption
Non-permeable
Oxygen barrier
Properties of the layers or laminate
Other properties
Permeability to gases, adsorption
Non-permeable
Water vapor barrier
Properties of the layers or laminate
Other properties
Thermoformability
Containers; Receptacles
Open containers
Containers; Receptacles
Closed containers
Bottles
Containers; Receptacles
Food packaging
Packaging equipment or accessories not otherwise provided for
Use of inorganic substances as compounding ingredients
Oxygen-containing compounds, e.g. metal carbonyls
Acids; Salts thereof
Carbonates; Bicarbonates
Calcium, strontium or barium carbonate
Use of inorganic substances as compounding ingredients
Silicon-containing compounds
Clay
Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Dyes of natural origin prepared from natural sources, e.g. vegetable sources
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bed-covers; Counterpanes; Travelling rugs; Sleeping rugs; Sleeping bags; Pillows
Bed-covers; Counterpanes; Travelling rugs; Sleeping rugs; Sleeping bags; Pillows comprising deodorising, fragrance releasing, therapeutic or disinfecting substances
Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Tea; Tea substitutes; Preparations thereof
Tea extraction; Tea extracts; Treating tea extract; Making instant tea
Addition of, or treatment with, enzymes or microorganisms
Tea; Tea substitutes; Preparations thereof
Tea substitutes, e.g. mat; Extracts or infusions thereof
Coffee; Coffee substitutes; Preparations thereof
Extraction of coffee; Coffee extracts; Making instant coffee
Addition of, or treatment with, enzymes or microorganisms
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Drugs for immunological or allergic disorders
Antiallergic agents
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Preparation of compounds containing saccharide radicals
Monosaccharides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing peptides
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Lactic or propionic acid bacteria
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
Serine endopeptidases (3.4.21)
Plasminogen activators
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Preparation of compounds containing saccharide radicals
Monosaccharides
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Penicillium
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Accessory food factors for animal feeding-stuffs
Organic substances
Accessory food factors for animal feeding-stuffs
Organic substances
Sugars; Polysaccharides
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
Carboxylic acids; Salts or anhydrides thereof
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus brevis
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus casei
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptococcus ; Enterococcus; Lactococcus
Medicinal preparations containing peptides
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the kidneys
Drugs for dermatological disorders
Antipsoriatics
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for immunological or allergic disorders
Antiallergic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
Genetically modified animals
Animals comprising random inserted nucleic acids (transgenic)
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Fusion polypeptide
Fusion polypeptide
Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Drugs for disorders of the respiratory system
Nasal agents, e.g. decongestants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Drugs for disorders of the respiratory system
Antiasthmatics
Drugs for dermatological disorders
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Antiallergic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving proteins of known structure or function as defined in the subgroups
Details
G-proteins
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Oligonucleotides characterized by their use
Plant traits
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Leaves
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Oligonucleotides characterized by their use
Plant traits
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a maytansine
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Detection or diagnosis of diseases
Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from lung cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Chewing gum
Chewing gum characterised by the composition containing organic or inorganic compounds
Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Shaping or working-up of animal feeding-stuffs
Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Biochemical treatment
Treatment with microorganisms
Slime forming bacteria; Exopolysaccharide or thickener producing bacteria, ropy cultures, so-called filant strains
Lactic or propionic acid bacteria
Streptococcus, lactococcus
Thermophilus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptococcus
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Hydrolases acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Pectinesterase (3.1.1.11)
Whey; Whey preparations
Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Thickening substances
Milk preparations; Milk powder or milk powder preparations
Milk preparations; Milk powder or milk powder preparations containing additives
Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
Acidified milk products containing thickening agents or acidified milk gels, e.g. acidified by fruit juices
Foods or foodstuffs containing additives; Preparation or treatment thereof
Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
Pectin; Derivatives thereof
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using actinomycetales
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the respiratory system
Drugs for dermatological disorders
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Xylulokinase (2.7.1.17)
Intramolecular oxidoreductases (5.3)
Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
Xylose isomerase (5.3.1.5)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Cells for large scale production
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Corynebacterium diphtheriae
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Milk preparations; Milk powder or milk powder preparations
Milk preparations; Milk powder or milk powder preparations containing additives
Milk preparations; Milk powder or milk powder preparations
Milk preparations; Milk powder or milk powder preparations containing additives
Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
Antibiotics; Bacteriocins; Fungicides from microorganisms
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Accessory food factors for animal feeding-stuffs
Organic substances
Meat products; Meat meal; Preparation or treatment thereof
Meat products; Meat meal; Preparation or treatment thereof
Meat products; Meat meal; Preparation or treatment thereof containing additives
Addition of, or treatment with, microorganisms
Products from fruits or vegetables; Preparation or treatment thereof
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Drugs for genital or sexual disorders; Contraceptives
Drugs for genital or sexual disorders; Contraceptives
Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Drugs for genital or sexual disorders; Contraceptives
Drugs for genital or sexual disorders; Contraceptives for impotence
Drugs for disorders of the metabolism
Nutrients, e.g. vitamins, minerals
General protective or antinoxious agents
Free radical scavengers or antioxidants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Rhamnosus
Lactic or propionic acid bacteria
Bifidobacterium
Longum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from lung cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from liver or pancreas cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from skin, nerves or brain cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of a blood cancer
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Drugs for disorders of the respiratory system
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the prostate
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the bladder
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the kidneys
Drugs for genital or sexual disorders; Contraceptives
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleosides
Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
IMP dehydrogenase (1.1.1.205)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on alpha -1,4-glucosidic bonds
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Alpha-glucosidase (3.2.1.20)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Corynebacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Homoserine dehydrogenase (1.1.1.3)
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from kidney or bladder cancer cell
Antineoplastic agents
Antineoplastic agents specific for metastasis
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
Medicinal preparations containing inorganic active ingredients
Heavy metals; Compounds thereof
Platinum; Compounds thereof
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a camptothecin [CPT] or derivatives
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from lung cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from liver or pancreas cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell
Antineoplastic agents
Antineoplastic agents specific for metastasis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Internalization into the cell
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for immunological or allergic disorders
Antiallergic agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Promoters of weight control and weight loss
Lactic or propionic acid bacteria
Lactobacillus
Brevis
Lactic or propionic acid bacteria
Lactobacillus
Johnsonii
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Lactic or propionic acid bacteria
Bifidobacterium
Longum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus brevis
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Powders or granules
Plant growth regulators
Nematocides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on beta-1,4-glucosidic bonds
Beta-glucosidase (3.2.1.21)
Preparation of peptides or proteins
Glycopeptides, glycoproteins
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (2.4.1.101)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids the nitrogen atom being doubly bound to the carbon skeleton
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazoles; Hydrogenated 1,3-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazines; Hydrogenated 1,3-diazines
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof containing the groups, or; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Streptomyces
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Streptomyces
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Preparation of nitrogen-containing organic compounds
Amines; Imines
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Preparation of nitrogen-containing organic compounds
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Diamine N-acetyltransferase (2.3.1.57)
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
Ortho-condensed systems
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Carbocyclic rings
Condensed ring systems having three or more rings
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Preparation of compounds containing saccharide radicals
Preparation of O-glycosides, e.g. glucosides
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Lactic acid
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Alcohol dehydrogenase (NADP+) (1.1.1.2), i.e. aldehyde reductase
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
D-Lactate dehydrogenase (1.1.1.28)
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Malate dehydrogenase (1.1.1.37)
Acyltransferases (2.3)
Acyl groups converted into alkyl on transfer (2.3.3)
ATP citrate synthase (2.3.3.8)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Pyruvate kinase (2.7.1.40)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Pyruvate decarboxylase (4.1.1.1)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Phosphoenolpyruvate carboxykinase (GTP) (4.1.1.32)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring nitrogenous groups (2.6)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Phosphoglycerate dehydrogenase (1.1.1.95)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
O-Phosphoserine sulfhydrylase (2.5.1.65)
Transferases transferring nitrogenous groups (2.6)
Transaminases (2.6.1)
Phosphoserine transaminase (2.6.1.52)
Hydrolases acting on ester bonds (3.1)
Phosphoric monoester hydrolases (3.1.3)
Phosphoserine phosphatase (3.1.3.3)
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Fungi, e.g. yeasts
Ascomycota
Saccharomycetales, e.g. baker's yeast
Drugs for dermatological disorders
Antipsoriatics
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Probiotics, living bacteria to be ingested for action in the digestive tract
Lactic or propionic acid bacteria
Lactobacillus
Rhamnosus
Lactic or propionic acid bacteria
Bifidobacterium
Animalis
Lactic or propionic acid bacteria
Bifidobacterium
Lactis
Lactic or propionic acid bacteria
Bifidobacterium
Longum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Drugs for disorders of the alimentary tract or the digestive system
Antidiarrhoeals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Casei
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Citrulline; Arginine; Ornithine
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring nitrogenous groups (2.6)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Transferases transferring nitrogenous groups (2.6)
Transaminases (2.6.1)
Aspartate transaminase (2.6.1.1), i.e. aspartate-aminotransferase
Carbon-nitrogen lyases (4.3)
Ammonia-lyases (4.3.1)
Aspartate ammonia-lyase (4.3.1.1), i.e. aspartase
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Finished or partly finished bakery products
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with a leaven or a composition containing acidifying bacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Lactic or propionic acid bacteria
Lactobacillus
Curvatus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Microorganisms ; Processes using microorganisms
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Finished or partly finished bakery products
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with a leaven or a composition containing acidifying bacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Lactic or propionic acid bacteria
Lactobacillus
Brevis
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus brevis
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism
Nutrients, e.g. vitamins, minerals
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Food compositions, function of food ingredients or processes for food or foodstuffs
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing antigens or antibodies
Viral antigens
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Specific hybridization probes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Viruses
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
DNA (RNA) vaccination
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Mucosal route
Mucosal route oral/gastrointestinal
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Mucosal route
Mucosal route intranasal
Medicinal preparations containing antigens or antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Filoviridae
Ebolavirus, e.g. Zaire ebolavirus
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Filoviridae
Ebolavirus, e.g. Zaire ebolavirus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Filoviridae
Ebolavirus, e.g. Zaire ebolavirus
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Filoviridae
Ebolavirus, e.g. Zaire ebolavirus
Use of virus, viral particle or viral elements as a vector
Special targeting system for viral vectors
Vectors comprising a targeting moiety
Vectors comprising as targeting moiety peptide derived from defined protein
Vectors comprising as targeting moiety peptide derived from defined protein from viruses
Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from viruses
RNA viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Kidney, bladder
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Hybridisation assays
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Hinge
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Framework region [FR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Oligonucleotides characterized by their use
Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Oligonucleotides characterized by their use
Polymorphic or mutational markers
Oligonucleotides characterized by their use
Expression markers
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Ortho-condensed systems
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
Heterocyclic compounds
Antineoplastic agents
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Anti-Parkinson drugs
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
General protective or antinoxious agents
Free radical scavengers or antioxidants
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of a blood cancer
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Antineoplastic agents
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
Diagnostic techniques
Diagnostic techniques involving the use of contrast agents
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
1,3-Diazoles
1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Non condensed pyridines; Hydrogenated derivatives thereof
Non condensed piperidines, e.g. piperocaine
Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
Medicinal preparations containing organic active ingredients
Phosphorus compounds
Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having three or more nucleosides or nucleotides
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having three or more nucleosides or nucleotides
Double-stranded nucleic acids or oligonucleotides
Medicinal preparations containing inorganic active ingredients
Heavy metals; Compounds thereof
Medicinal preparations containing inorganic active ingredients
Heavy metals; Compounds thereof
Platinum; Compounds thereof
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Carcino-embryonic antigens
Antineoplastic agents
Antineoplastic agents specific for metastasis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Carcino-embryonic Antigens
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Lung
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Blood cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated mucins
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Comprising a combination of two or more separate antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Internalization into the cell
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Stability, e.g. half-life, pH, temperature or enzyme-resistance
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
Enzymes or microbial cells immobilised on or in an inorganic carrier
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on a heme group of donors (1.9)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Biological synthesis; Biological purification
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Carbocyclic rings
Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Inorganic compounds
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a camptothecin [CPT] or derivatives
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Carcino-embryonic antigens
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from lung cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from liver or pancreas cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Medicinal preparations characterised by special physical form
Solutions
Antineoplastic agents
Antineoplastic agents specific for metastasis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Carcino-embryonic Antigens
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Preparation of nitrogen-containing organic compounds
Amines; Imines
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Phosphogluconate dehydrogenase (decarboxylating) (1.1.1.44)
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Glucose-6-phosphate dehydrogenase (1.1.1.49)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
Glyceraldehyde-3-phosphate dehydrogenase (NADP+) (phosphorylating) (1.2.1.13)
Oxidoreductases acting on NADH or NADPH (1.6)
Oxidoreductases acting on NADH or NADPH (1.6) with NAD+ or NADP+ as acceptor (1.6.1)
NAD(P)+ transhydrogenase (B-specific) (1.6.1.1)
Oxidoreductases acting on NADH or NADPH (1.6)
Oxidoreductases acting on NADH or NADPH (1.6) with NAD+ or NADP+ as acceptor (1.6.1)
NAD(P)+ Transhydrogenase (AB-specific) (1.6.1.2)
Transferases transferring aldehyde or ketonic groups (2.2)
Transketolases and transaldolases (2.2.1)
Transketolase (2.2.1.1)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Diamine N-acetyltransferase (2.3.1.57)
Glycosyltransferases (2.4)
Pentosyltransferases (2.4.2)
Nicotinate phosphoribosyltransferase (2.4.2.11)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
Gluconokinase (2.7.1.12)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with an alcohol group as acceptor (2.7.1)
NAD+ kinase (2.7.1.23)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Ornithine decarboxylase (4.1.1.17)
Ligases forming carbon-nitrogen bonds (6.3)
Other carbon-nitrogen ligases (6.3.4)
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Flowers
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Flowers
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Milk substitutes, e.g. coffee whitener compositions
Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
Addition of, or treatment with, microorganisms
Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
Drinks from legumes, e.g. lupine drinks
Soy drinks
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Curvatus
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Flowers
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Blood cells
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Non condensed pyridines; Hydrogenated derivatives thereof
Non condensed piperidines, e.g. piperocaine
Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from liver or pancreas
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Carcino-embryonic Antigens
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Lung
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Kidney, bladder
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Skin, nerves, brain
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated mucins
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Internalization into the cell
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Finished or partly finished bakery products
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with a leaven or a composition containing acidifying bacteria
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with yeasts
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food ingredients
Yeasts
Saccharomyces
Lactic or propionic acid bacteria
Lactobacillus
Brevis
Lactic or propionic acid bacteria
Lactobacillus
Curvatus
Lactic or propionic acid bacteria
Lactobacillus
Sanfranciscenis
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus brevis
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
1,3-Diazoles
1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Non condensed pyridines; Hydrogenated derivatives thereof
Non condensed piperidines, e.g. piperocaine
Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
Medicinal preparations containing organic active ingredients
Phosphorus compounds
Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having saccharide radicals and heterocyclic rings
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having three or more nucleosides or nucleotides
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Compounds having three or more nucleosides or nucleotides
Double-stranded nucleic acids or oligonucleotides
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from liver or pancreas cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Carcino-embryonic Antigens
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Radiation therapy
X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
Sources therefor
Radioactive fluid
Radiation therapy
X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Internalization into the cell
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Stability, e.g. half-life, pH, temperature or enzyme-resistance
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing organic active ingredients
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic orhydroximic acids
Carboxylic acids, e.g. valproic acid
Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Fungi, e.g. yeasts
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Preparations for care of the skin
Preparation of wine or sparkling wine
Preparation of must from grapes; Must treatment and fermentation
Preparation of must from grapes; Must treatment and fermentation by microbiological or enzymatic treatment
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Food compositions, function of food ingredients or processes for food or foodstuffs
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Chemical, physico-chemical or functional or structural properties of particular ingredients
Stabilizers
Antioxidants; Radical scavengers
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Serratia
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Alanine; Leucine; Isoleucine; Serine; Homoserine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Methionine; Cysteine; Cystine
Preparation of thiols, sulfides, hydropolysulfides or polysulfides
Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by replacement of hydroxy groups or etherified or esterified hydroxy groups
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Phosphotransferases with a carboxyl group as acceptor (2.7.2)
Transferases transferring phosphorus-containing groups (2.7)
Phosphotransferases with a carboxy group as acceptor (2.7.2)
Aspartate kinase (2.7.2.4)
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Complete heavy chain or Fd fragment, i.e. VH + CH1
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Fusion polypeptide
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Specific hybridization probes
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Paramyxoviridae, e.g. parainfluenza virus
Drugs for disorders of the respiratory system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Paramyxoviridae, e.g. respiratory syncytial virus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Viruses
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus expressing foreign proteins
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Respirovirus, e.g. Bovine, human parainfluenza 1,3
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Oligonucleotides characterized by their use
Expression markers
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Carboxylic acid amides
Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
Medicinal preparations containing organic active ingredients
Amides, e.g. hydroxamic acids
Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
Medicinal preparations containing organic active ingredients
Amines
Amines having aromatic rings, e.g. ketamine, nortriptyline
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of peptides or proteins
Preparation of peptides or proteins
Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Polycarboxylic acids
Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Antineoplastic agents
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
Dipeptides
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Carbon-oxygen lyases (4.2)
Hydro-lyases (4.2.1)
Hydroperoxide dehydratase (4.2.1.92)
Carbon-oxygen lyases (4.2)
Other carbon-oxygen lyases (4.2.99)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of two atoms of oxygen (1.13.11)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Drugs for disorders of the respiratory system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus subtilis ; Hay bacillus; Grass bacillus
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Drugs for disorders of the respiratory system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus subtilis ; Hay bacillus; Grass bacillus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Nucleotidyltransferases (2.7.7)
DNA-directed RNA polymerase (2.7.7.6)
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Preparation of peptides or proteins
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Transferases transferring phosphorus-containing groups (2.7)
Nucleotidyltransferases (2.7.7)
DNA-directed RNA polymerase (2.7.7.6)
Nucleic acids vectors
Plasmid DNA
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Libraries per se, e.g. arrays, mixtures
Libraries containing only organic compounds
Libraries containing nucleotides or polynucleotides, or derivatives thereof
Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Isolating an individual clone by screening libraries
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
General methods for enhancing the expression
Increasing the copy number of the vector
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Nucleotidyltransferases (2.7.7)
DNA-directed RNA polymerase (2.7.7.6)
Nucleic acids vectors
Plasmid DNA
Plasmid DNA for bacteria
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
Transferases transferring phosphorus-containing groups (2.7)
Nucleotidyltransferases (2.7.7)
DNA-directed RNA polymerase (2.7.7.6)
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Pulmonary tract; Aromatherapy
Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Drugs for disorders of the respiratory system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Fungi, e.g. yeasts
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Drugs for dermatological disorders
Drugs for dermatological disorders
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Drugs for dermatological disorders
Antipruritics
Drugs for dermatological disorders
Antipsoriatics
Drugs for dermatological disorders
Anti-acne agents
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Preparations for care of the skin
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Preparations for care of the skin
Anti-ageing preparations
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Polyesters of hydroxy carboxylic acids
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Acetoacetyl-CoA reductase (1.1.1.36)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Acetyl-CoA C-acyltransferase (2.3.1.16)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Algae ; Processes using algae
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Triticum sp. [wheat]
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazoles; Hydrogenated 1,3-diazoles
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
Sulfonylurea
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Carbon-carbon lyases (4.1)
Oxo-acid-lyases (4.1.3)
Oligonucleotides characterized by their use
Plant traits
Oligonucleotides characterized by their use
Polymorphic or mutational markers
Oligonucleotides characterized by their use
Expression markers
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
1,3-Thiazoles; Hydrogenated 1,3-thiazoles
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,3-Diazines; Hydrogenated 1,3-diazines
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
1,2-Diazoles; Hydrogenated 1,2-diazoles
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
O-Aryl or S-Aryl esters thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof
Carbamic acid derivatives, i.e. containing the group OCON<; Thio analogues thereof containing the groups, or; Thio analogues thereof
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
Ureas or thioureas containing the groups >NCON< or >NCSN<
Derivatives containing the group >NCON aryl or >NCSNaryl
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Zea mays [maize]
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Plant growth regulators
Drugs for disorders of the metabolism
Nutrients, e.g. vitamins, minerals
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Disaccharides, e.g. lactose, lactulose
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Milk; Whey; Colostrum
Medicinal preparations containing peptides
Hydrolysed proteins; Derivatives thereof
Hydrolysed proteins; Derivatives thereof from animals
Hydrolysed proteins; Derivatives thereof from animals from milk
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Lactic or propionic acid bacteria
Bifidobacterium
Breve
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Preparation of compounds containing saccharide radicals
Monosaccharides
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using fungi
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Mycobacterium
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Hydrangeacae, e.g. Hydrangea
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Flowers
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Oligonucleotides characterized by their use
Plant traits
Oligonucleotides characterized by their use
Polymorphic or mutational markers
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Isolating an individual clone by screening libraries
Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Mutagenizing nucleic acids
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
Medicinal preparations containing organic active ingredients
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for dermatological disorders
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of prostate
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Plant toxins
Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Stable introduction of foreign DNA into chromosome
Stable introduction of foreign DNA into chromosome using homologous recombination
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol the polymer being PLGA, PLA or polyglycolic acid
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Lectins
Medicinal preparations containing peptides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Medicinal preparations containing peptides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus thuringiensis
Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Molecules with a "CD"-designation not provided for elsewhere
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Isolating an individual clone by screening libraries
Preparation or screening of expression libraries, e.g. reporter assays
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Methylomonas
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Specific hybridization probes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Orthomyxoviridae
Influenzavirus A, i.e. influenza A virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Orthomyxoviridae
Influenzavirus B, i.e. influenza B virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Pneumovirus, e.g. human respiratory syncytial virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Coronaviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Rhizobium
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing the quinoid structure
Accessory food factors for animal feeding-stuffs
Organic substances
Aromatic compounds
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of carboxylic acids or their salts, halides or anhydrides
Preparation of carboxylic acids or their salts, halides or anhydrides from salts of carboxylic acids
Preparation of carboxylic acids or their salts, halides or anhydrides
Separation; Purification; Stabilisation; Use of additives
Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Preparation of carboxylic acids or their salts, halides or anhydrides
Preparation of carboxylic acids or their salts, halides or anhydrides from salts of carboxylic acids
Preparation of carboxylic acids or their salts, halides or anhydrides
Separation; Purification; Stabilisation; Use of additives
Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Methylomonas
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Polynucleotides, e.g. nucleic acids, oligoribonucleotides
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Preparation of elements or inorganic compounds except carbon dioxide
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Rhizobium
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Non condensed pyridines; Hydrogenated derivatives thereof
Medicinal preparations containing organic active ingredients
Amides, e.g. hydroxamic acids
Amides, e.g. hydroxamic acids having the group >NC(O)N< or >NC(S)N<, e.g. urea, thiourea, carmustine
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Drugs for immunological or allergic disorders
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Oligonucleotides characterized by their use
Expression markers
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of skin, e.g. melanoma
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of liver, pancreas or kidney
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of ovaries
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations for testing in vivo
Preparation for luminescence or biological staining
Luminescence
Fluorescence in vivo
Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
Preparations for testing in vivo
Preparation for luminescence or biological staining
Luminescence
Fluorescence in vivo
Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
Antibodies
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Fused cells, e.g. hybridomas
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin the drug being a peptidic cytokine, e.g. an interleukin or interferon
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Enzymes
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Fused cells, e.g. hybridomas
Animal cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Medicinal preparations containing organic active ingredients
Phosphorus compounds
Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
Medicinal preparations containing peptides
Peptides of undefined number of amino acids; Derivatives thereof
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Drugs for disorders of the respiratory system
Drugs for disorders of the respiratory system
Antiasthmatics
Drugs for dermatological disorders
Drugs for dermatological disorders
Antipsoriatics
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for skeletal disorders
Antigout agents, e.g. antihyperuricemic or uricosuric agents
Drugs for disorders of the muscular or neuromuscular system
Drugs for disorders of the nervous system
Drugs for disorders of the senses
Ophthalmic agents
Drugs for disorders of the senses
Otologicals
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Drugs for disorders of the metabolism
Antihyperlipidemics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for disorders of the endocrine system
Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Drugs for disorders of the endocrine system
Drugs for disorders of the endocrine system of the parathyroid hormones
Drugs for disorders of the blood or the extracellular fluid
Drugs for disorders of the cardiovascular system
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
Drugs for disorders of the nervous system
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Genetically modified cells
Genetically modified cells
Cells for production
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of ovaries
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of breast
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
Laccase (1.10.3.2)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Processes using, or culture media containing, cellulose or hydrolysates thereof
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
Preparation of carboxylic acids or their salts, halides or anhydrides
Separation; Purification; Stabilisation; Use of additives
Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
Preparation of carboxylic acids or their salts, halides or anhydrides
Separation; Purification; Stabilisation; Use of additives
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from blood cells, e.g. the cancer being a myeloma
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Antineoplastic agents
Antineoplastic agents specific for metastasis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers leukemia
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Embryonic cells ; Embryoid bodies
Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Specific components of cell culture medium
Inorganic components
Metals; Metal chelators
Transition metals
Iron; Fe chelators; Transferrin
Insulin-transferrin; Insulin-transferrin-selenium
Active agents used in cell culture processes, e.g. differentation
Growth factors
Epidermal growth factor [EGF]
Active agents used in cell culture processes, e.g. differentation
Cytokines; Chemokines
Interleukins [IL]
Leukemia inhibitory factor [LIF]
Active agents used in cell culture processes, e.g. differentation
Hormones
Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
Cells related to new breeds of animals
Conditioning of cells for in vitro fecondation or nuclear transfer
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Paramyxoviridae, e.g. parainfluenza virus
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Paramyxoviridae, e.g. respiratory syncytial virus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Viruses
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Mucosal route
Mucosal route intranasal
Medicinal preparations containing antigens or antibodies
Multivalent vaccine
Preparations for testing in vivo
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Pneumovirus, e.g. human respiratory syncytial virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Pneumovirus, e.g. human respiratory syncytial virus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Respirovirus, e.g. Bovine, human parainfluenza 1,3
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Respirovirus, e.g. Bovine, human parainfluenza 1,3
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Respirovirus, e.g. Bovine, human parainfluenza 1,3
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Respirovirus, e.g. Bovine, human parainfluenza 1,3
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Rickettsiales, e.g. Anaplasma
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Rickettsiales (O)
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Veterinary vaccine
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Organic adjuvants
Emulsions, e.g. Freund's adjuvant, MF59
Medicinal preparations containing antigens or antibodies
Multivalent vaccine
Medicinal preparations containing antigens or antibodies
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Birnaviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Birnaviridae
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DNA sequences coding for fusion proteins
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Hepatitis virus
Medicinal preparations containing antigens or antibodies
Haptens or antigens, bound to carriers
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for influenza or rhinoviruses
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
RNA viruses
Togaviridae; Flaviviridae
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
Proteins
Antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
Fusion polypeptide
Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
Compounds containing elements of Groups 5 or 15 of the Periodic Table
Phosphorus compounds
Phosphorus compounds with one or more PC bonds
Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
Acyclic saturated acids which can have further substituents on alkyl
Compounds containing elements of Groups 5 or 15 of the Periodic Table
Phosphorus compounds
Phosphorus compounds with one or more PC bonds
Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Antiparasitic agents
Antineoplastic agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell proliferation
Working-up of proteins for foodstuffs
Working-up of proteins for foodstuffs by hydrolysis
Working-up of proteins for foodstuffs by hydrolysis using chemical agents
Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
Working-up of proteins for foodstuffs
Animal proteins
Dairy proteins
Casein
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Proteins
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Peptides; Protein hydrolysates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Casein
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Linear peptides containing only normal peptide links
Linear peptides containing only normal peptide links having 12 to 20 amino acids
Preparation of peptides or proteins
Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Food compositions, function of food ingredients or processes for food or foodstuffs
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Comprising a combination of two or more separate antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
Assays involving biological materials from specific organisms or of a specific nature
Enzymes; Proenzymes
Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Acetic acid
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Preparation of polysaccharides not provided for in groups C08B1/00-C08B35/00; Derivatives thereof
Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Chitosanase (3.2.1.132)
Medicinal preparations containing peptides
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Dipeptides
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Containers specially adapted for medical or pharmaceutical purposes
Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
1,3-Diazoles
1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
1,4-Oxazines, e.g. morpholine
1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
Medicinal preparations containing organic active ingredients
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
Medicinal preparations containing organic active ingredients
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being an auristatin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from kidney or bladder cancer cell
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Metalloendopeptidases (3.4.24), e.g. collagenase
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Drugs for disorders of the cardiovascular system
Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Medicinal preparations containing peptides
Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
Metalloendopeptidases (3.4.24)
Aureolysin (3.4.24.29)
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
Organic compounds; Microorganisms; Enzymes
Microorganisms; Enzymes
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from bacteria
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Gene or protein expression profiling; Expression-ratio estimation or normalisation
Subject matter not provided for in other groups of this subclass
ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Detection or diagnosis of diseases
Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Extraction; Separation; Purification
Extraction; Separation; Purification by chromatography
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Extraction; Separation; Purification
Extraction; Separation; Purification by chromatography
Ion-exchange chromatography
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Extraction; Separation; Purification
Extraction; Separation; Purification by chromatography
Affinity chromatography or related techniques based upon selective absorption processes
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Extraction; Separation; Purification
Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
Extraction; Separation; Purification
Extraction; Separation; Purification by a combination of two or more processes of different types
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Framework region [FR]
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Medicinal preparations characterised by special physical form
Galenical forms characterised by the site of application
Mouth and digestive tract, i.e. intraoral and peroral administration
Medicinal preparations characterised by special physical form
Galenical forms not covered by A61K9/02-A61K9/7023
Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using fungi
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Food compositions, function of food ingredients or processes for food or foodstuffs
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated mucins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Comprising a combination of two or more separate antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Stability, e.g. half-life, pH, temperature or enzyme-resistance
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Animals; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Paenibacillus
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Rhizobium
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Lactic acid
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
Aldehyde dehydrogenase (NAD+) (1.2.1.3)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Pyruvate decarboxylase (4.1.1.1)
Ligases forming carbon-sulfur bonds (6.2)
Acid-Thiol Ligases (6.2.1)
Acetate-CoA ligase (6.2.1.1)
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Pseudomonas
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Flowers
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Leaves
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Cannabaceae, e.g. cannabis
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Hybridisation assays
Hybridisation assays for detection of mutation or polymorphism
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
1,4-Benzodiazepines, e.g. diazepam or clozapine
1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Antineoplastic agents
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
Dipeptides
Dipeptides with the first amino acid being neutral
Dipeptides with the first amino acid being neutral and aliphatic
Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
Val-amino acid
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Consortia of bacteria
Biological treatment of water, waste water, or sewage
Aerobic processes
Packings; Fillings; Grids
Biological treatment of water, waste water, or sewage
Anaerobic digestion processes
Anaerobic processes using solid supports for microorganisms
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Biological treatment of water, waste water, or sewage characterised by the microorganisms used characterised by the way or the form in which the microorganisms are added or dosed
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Treatment of water, waste water, or sewage
Treatment of water, waste water, or sewage by sorption
Treatment of water, waste water, or sewage by sorption using inorganic sorbents
Biological treatment of water, waste water, or sewage
Aerobic processes
Packings; Fillings; Grids
Characterized by the chemical composition
Inorganic materials, e.g. sand, silicates
Technologies for wastewater treatment
Biological treatment of water, waste water, or sewage
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Accessory food factors for animal feeding-stuffs
Organic substances
Use of ingredients of unknown constitution, e.g. undefined reaction products
Use of organic ingredients
Oxygen-containing compounds
Heterocyclic compounds having oxygen in the ring
Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
Six-membered rings
Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
Starch; Degradation products thereof, e.g. dextrin
Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
Dextran; Derivatives thereof
Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
Alginic acid; Derivatives thereof
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Preserving or maintaining viable microorganisms
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
Enzymes or microbial cells immobilised on or in an organic carrier
Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Buttermilk; Buttermilk preparations
Buttermilk; Buttermilk preparations containing, or treated with, microorganisms or enzymes
Cheese; Cheese preparations; Making thereof
Treating cheese curd after whey separation; Products obtained thereby
Addition of, or treatment with, microorganisms
Addition of, or treatment with, microorganisms using only lactic acid bacteria, e.g. pediococcus, leconostoc or bifidus sp., or propionic acid bacteria; Treatment with non-specified acidifying bacterial cultures
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Fruit or vegetables
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Thickening substances
Foods or foodstuffs containing additives; Preparation or treatment thereof
Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Vitamins
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Inorganic salts, minerals or trace elements
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Reducing nutritive value; Dietetic products with reduced nutritive value
Addition of substantially indigestible substances, e.g. dietary fibres
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Dietetic or nutritional methods, e.g. for losing weight
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Fructosans, e.g. inulin
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Glucomannans or galactomannans, e.g. locust bean gum, guar gum
Medicinal preparations containing inorganic active ingredients
Heavy metals; Compounds thereof
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by special physical form
Preparations in capsules, e.g. of gelatin, of chocolate
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Antihyperlipidemics
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system
Antihypertensives
Food compositions, function of food ingredients or processes for food or foodstuffs
Lactic or propionic acid bacteria
Lactobacillus
Bulgaricus
Lactic or propionic acid bacteria
Lactobacillus
Delbrueckii
Lactic or propionic acid bacteria
Streptococcus, lactococcus
Thermophilus
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Medicinal preparations comprising living procariotic cells
Probiotics
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Hepatocytes
Stem cells; Progenitor cells; Precursor cells; Oval cells
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Digestive system
Liver; Hepatocytes
Materials for grafts or prostheses or for coating grafts or prostheses
Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Cells of the gastro-intestinal tract
Stem cells; Progenitors
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
Liver cells
Specific components of cell culture medium
Inorganic components
Specific components of cell culture medium
Organic components
Vitamins
Active agents used in cell culture processes, e.g. differentation
Growth factors
Insulin-like growth factors [IGF]
Active agents used in cell culture processes, e.g. differentation
Growth factors
Basic fibroblast growth factor (bFGF, FGF-2)
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Genetically modified cells
Genetically modified cells
Immortalised cells
Supports or coatings for cell culture, characterised by material
Proteins
Collagen; Gelatin
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleosides
Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations containing organic active ingredients
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interleukins [IL]
IL-2
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interferons [IFN]
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Non condensed pyridines; Hydrogenated derivatives thereof
Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Non-condensed pyrazines
Non-condensed pyrazines containing further heterocyclic rings
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Oligonucleotides characterized by their use
Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Oligonucleotides characterized by their use
Prognosis of disease development
Oligonucleotides characterized by their use
Screening for pharmacological compounds
Oligonucleotides characterized by their use
Expression markers
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Ribonucleases RNAses, DNAses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Mutagenizing nucleic acids
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Butanols
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Structure or type of the nucleic acid
Type of nucleic acid
Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Clostridium
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Animal feeding-stuffs
Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
Feeding-stuffs specially adapted for particular animals
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
Geranylgeranyl diphosphate synthase (2.5.1.29)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
(2E,6E)-Farnesyl diphosphate synthase (2.5.1.10), i.e. geranyltranstransferase
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the alimentary tract or the digestive system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Zea mays [maize]
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Zea mays [maize]
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
1,4-Benzodiazepines, e.g. diazepam or clozapine
1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of a blood cancer
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Antineoplastic agents
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
Zea mays [maize]
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Powders or granules
Disinfectants; Antimicrobial compounds or mixtures thereof
Fungicides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Apparatus, or methods of use thereof, for testing or treating seed, roots, or the like, prior to sowing or planting
Immunising seed
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus licheniformis
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus subtilis ; Hay bacillus; Grass bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
Alcohols
Phenols
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Vitamins
Tocopherol, i.e. vitamin E
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Preparations for care of the skin
Preparations for care of the skin
Anti-ageing preparations
Preparations for care of the hair
Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
Additives
Stabilisers against degradation by oxygen, light or heat
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Lysis of microorganisms
Lysis of microorganisms by physical methods
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Chemical, physico-chemical or functional or structural properties of particular ingredients
Stabilizers
Antioxidants; Radical scavengers
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Corresponding aspects not provided for by any of codes A61K2800/81-A61K2800/95
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Preparation or application process involves sonication or ultrasonication
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Products or compounds obtained by lyophilisation, freeze-drying
Use of ingredients of unknown constitution, e.g. undefined reaction products
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Brassicaceae, e.g. canola, broccoli or rucola
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Ethanol, i.e. non-beverage with microorganisms other than yeasts
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Chemistry: molecular biology and microbiology
Continuous fermentation
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
General methods for enhancing the expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Xylanases
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,4-beta-xylanase (3.2.1.8)
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,4-beta-xylanase (3.2.1.8)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
Beta-lactamase (3.5.2.6)
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Xylanases
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,4-beta-xylanase (3.2.1.8)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
Beta-lactamase (3.5.2.6)
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Drugs for dermatological disorders
Emollients or protectives, e.g. against radiation
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing peptides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Micrococcus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Micrococcus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by desacylation of the substituent in the 7 position
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Medicinal preparations containing peptides
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Urokinase; Tissue plasminogen activator
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Chemistry: molecular biology and microbiology
Kit
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Protease inhibitors
Endopeptidase (E.C. 3.4.21-99) inhibitors
Serine protease (E.C. 3.4.21) inhibitors
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Plant toxins
Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Protease inhibitors
Endopeptidase (E.C. 3.4.21-99) inhibitors
Serine protease (E.C. 3.4.21) inhibitors
Medicinal preparations containing peptides
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using fungi
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing peptides
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Togaviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Proteins from microorganisms
Viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing peptides
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Proteins from microorganisms
Viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing peptides
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
Medicinal preparations containing peptides
Peptide or protein sequence
Peptide or protein sequence
Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system containing a 2-oxo-thieno[3,4-d]imidazol nucleus, e.g. Biotin
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Hormones
Calcitonins
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Preparation of peptides or proteins
Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Making spongy iron or liquid steel, by direct processes
Making spongy iron or liquid steel, by direct processes obtaining iron or steel in a molten state
Making spongy iron or liquid steel, by direct processes obtaining iron or steel in a molten state introduction of iron oxide into a bath of molten iron containing a carbon reductant
Reduction of iron ores by passing through a heated column of carbon
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Technologies related to metal processing
Reduction of greenhouse gas [GHG] emissions
Reduction of greenhouse gas [GHG] emissions by avoiding CO2, e.g. using hydrogen
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Immunoglobulins
Antibody fragments
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Detection or diagnosis of diseases
Immunology or allergic disorders
Chemistry: molecular biology and microbiology
Kit
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Testing for sterility conditions
Oxidoreductases acting on a peroxide as acceptor (1.11)
Peroxidases (1.11.1)
Catalase (1.11.1.6)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Micrococcus
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
Carbocyclic rings
Condensed ring systems having three or more rings
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antimycotics
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Preparation of compounds containing saccharide radicals
Preparation of O-glycosides, e.g. glucosides
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Pseudomonas
Pseudomonas putida
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Pseudomonas putida
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Pseudomonas
Pseudomonas putida
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Animal cells
White blood cells
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Molecules with a "CD"-designation not provided for elsewhere
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Medicinal preparations containing peptides
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
CD71
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Reverse transcribing RNA viruses
Details
Retroviridae
Gammaretrovirus, e.g. murine leukeamia virus
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription from viruses
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES having multiple IRES
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Refiningof hydrocarbon oils by electric or magnetic means, by irradiation, or by using microorganisms
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Nocardia
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Refiningof hydrocarbon oils by electric or magnetic means, by irradiation, or by using microorganisms
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Fusion polypeptide
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system containing a 2-oxo-thieno[3,4-d]imidazol nucleus, e.g. Biotin
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
General methods for enhancing the expression
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Ethanol, i.e. non-beverage with microorganisms other than yeasts
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Butanols
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carbonyl group
Ketones
Acetone-containing products
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
Drugs for disorders of the muscular or neuromuscular system
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Protease inhibitors
Endopeptidase (E.C. 3.4.21-99) inhibitors
Serine protease (E.C. 3.4.21) inhibitors
Medicinal preparations containing peptides
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving lignin biosynthesis
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Epidermal growth factor [EGF], i.e. urogastrone
Antineoplastic agents
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Angiogenesic factors; Angiogenin
Medicinal preparations containing peptides
Fusion polypeptide
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with yeasts
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, Ometal, CHO, keto, ether, groups, groups, or groups
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Preparation of carboxylic acids or their salts, halides or anhydrides
Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
Preparation of carboxylic acids or their salts, halides or anhydrides
Separation; Purification; Stabilisation; Use of additives
Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation by distillation
Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using actinomycetales
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptomyces
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of prostate
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Acetoacetyl-CoA reductase (1.1.1.36)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Acetyl-CoA C-acyltransferase (2.3.1.16)
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Viruses
HIV or HTLV
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Exopeptidases (3.4.11. to 3.4.19)
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of breast
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Chemistry: molecular biology and microbiology
Kit
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Medicinal preparations containing organic active ingredients
Carbohydrates; Sugars; Derivatives thereof
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of polysaccharides not provided for in groups C08B1/00-C08B35/00; Derivatives thereof
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Vitamins
Vitamins A or D
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Processes involving microorganisms of different genera in the same process, simultaneously
Food compositions, function of food ingredients or processes for food or foodstuffs
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Igs containing Ig-regions, -domains or -residues form different species
Igs with modifications in the FR-residues only
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Preparation of nitrogen-containing organic compounds
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Preparation of nitrogen-containing organic compounds
Nitriles (-CN)
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Methods of production or purification of viral material
Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription being a stuffer
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription from viruses
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
Geranylgeranyl diphosphate synthase (2.5.1.29)
Technologies for the production of fuel of non-fossil origin
Fuel from waste, e.g. synthetic alcohol or diesel
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Eicosapentaenoic acids [EPA]
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Accessory food factors for animal feeding-stuffs
Organic substances
Fatty acids; Fats; Products containing oils or fats
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Testing for antimicrobial activity of a material
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Specific hybridization probes
Specific hybridization probes for retroviruses
Viruses associated with AIDS
Reverse transcribing RNA viruses
Details
Retroviridae
Human Immunodeficiency Virus, HIV
Human Immunodeficiency Virus, HIV concerning HIV gagpol
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Immunoglobulin superfamily
CD28, CD152
Genetically modified animals
Animals comprising random inserted nucleic acids (transgenic)
Genetically modified animals
Animals genetically altered by homologous recombination
Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
Medicinal preparations containing peptides
Fusion polypeptide
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Clostridium, e.g. Clostridium tetani
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Mucosal route
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Organic adjuvants
Bacterial toxins
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Technologies for the production of fuel of non-fossil origin
Fuel from waste, e.g. synthetic alcohol or diesel
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Porphyrin- or corrin-ring-containing peptides
Haemoglobins; Myoglobins
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
1,4-Benzodiazepines, e.g. diazepam or clozapine
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
Antineoplastic agents
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
[b, e]- or [b, f]-condensed with six-membered rings
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Micromonospora
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
Insecticides
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Proteins from microorganisms
Bacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Transferrins, e.g. lactoferrins, ovotransferrins
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
Coordinates from 3D structures of peptides, e.g. proteins or enzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
Geranylgeranyl diphosphate synthase (2.5.1.29)
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Methylomonas
Processes for modifying genotypes ; Plants characterised by associated natural traits
Processes of selection involving genotypic or phenotypic markers; Methods of using phenotypic markers for selection
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Fruits
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Solanaceae, e.g. pepper, tobacco, potato, tomato or eggplant
Solanum lycopersicum [tomato]
Oligonucleotides characterized by their use
Plant traits
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Isolating an individual clone by screening libraries
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Stable introduction of foreign DNA into chromosome
Stable introduction of foreign DNA into chromosome using homologous recombination
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Preparation of steroids
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Polyesters of hydroxy carboxylic acids
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing the quinoid structure
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Bacillus
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Nitrogen as only ring hetero atom containing a six-membered hetero ring
Preparation of peptides or proteins
Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
Geranylgeranyl diphosphate synthase (2.5.1.29)
Technologies for the production of fuel of non-fossil origin
Fuel from waste, e.g. synthetic alcohol or diesel
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
[b, e]- or [b, f]-condensed with six-membered rings
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
Medicinal preparations containing peptides
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Micromonospora
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Vitamins
Vitamins A or D
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Processes involving microorganisms of different genera in the same process, simultaneously
Food compositions, function of food ingredients or processes for food or foodstuffs
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Proteins; Peptides; Derivatives or degradation products thereof
Drugs for dermatological disorders
Drugs for dermatological disorders for baldness or alopecia
Preparations for affecting hair growth
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Fibroblast growth factor [FGF]
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Medicinal preparations containing peptides
Detection or diagnosis of diseases
Dermatological disorders
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
[b, e]- or [b, f]-condensed with six-membered rings
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring aldehyde or ketonic groups (2.2)
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Fruits
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Cucurbitaceae, e.g. bitter melon, cucumber or watermelon
Cucurbita, e.g. squash or pumpkin
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Nucleoproteins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Reverse transcribing RNA viruses
Details
Retroviridae
Human Immunodeficiency Virus, HIV
Human Immunodeficiency Virus, HIV concerning HIV env
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Reverse transcribing RNA viruses
Details
Retroviridae
Human Immunodeficiency Virus, HIV
Human Immunodeficiency Virus, HIV concerning HIV gagpol
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Orthomyxoviridae
Influenzavirus A, i.e. influenza A virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Orthomyxoviridae
Influenzavirus A, i.e. influenza A virus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Orthomyxoviridae
Influenzavirus A, i.e. influenza A virus
Methods of production or purification of viral material
Nucleic acids vectors
Plasmid DNA
Plasmid DNA episomal vectors
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription from viruses
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Animal cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of liver, pancreas or kidney
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Oligonucleotides characterized by their use
Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Oligonucleotides characterized by their use
Disease subtyping, staging or classification
Oligonucleotides characterized by their use
Prognosis of disease development
Oligonucleotides characterized by their use
Expression markers
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Antineoplastic agents
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
RNA viruses
Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Medicinal preparations containing peptides
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
Processes involving microorganisms of different genera in the same process, simultaneously
Dumping solid waste
Destroying solid waste or transforming solid waste into something useful or harmless
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Recovery or working-up of waste materials
Recovery or working-up of waste materials of polymers
Recovery or working-up of waste materials of polymers by chemically breaking down the molecular chains of polymers or breaking of crosslinks, e.g. devulcanisation
Recovery or working-up of waste materials of polymers by chemically breaking down the molecular chains of polymers or breaking of crosslinks, e.g. devulcanisation by treatment with enzymes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
Polyesters derived from hydroxy carboxylic acids, e.g. lactones
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Technologies for solid waste management
Reuse, recycling or recovery technologies
Plastics recycling; Rubber recycling
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using fungi
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
Fusion polypeptide
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
New or modified breeds of vertebrates
Genetically modified vertebrates, e.g. transgenic
Knock-out vertebrates
Preparations for testing in vivo
Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
Genetically modified animals
Animals genetically altered by homologous recombination
Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
Animals characterised by species
Mammal
Murine
Animals characterised by purpose
Animal model, e.g. for test or diseases
Animal model for multifactorial diseases
Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving hydantoins or carbamoylamino compounds
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DNA sequences coding for fusion proteins
Fusion polypeptide
Fusion polypeptide containing a tag with affinity for a non-protein ligand
Fusion polypeptide
Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations containing organic active ingredients
Amides, e.g. hydroxamic acids
Sulfonamides
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
1,2-Diazoles
1,2-Diazoles non condensed and containing further heterocyclic rings
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
Thiazoles
Thiazoles condensed with carbocyclic rings
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Non condensed pyridines; Hydrogenated derivatives thereof
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Quinolines; Isoquinolines
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Accessory food factors for animal feeding-stuffs
Organic substances
Fatty acids; Fats; Products containing oils or fats
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Fatty acids or derivatives thereof; Fats or oils
Fatty acids or derivatives thereof
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Miscellaneous (1.14.99)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Linoleic acids [18:2[n-6]]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Eicosapentaenoic acids [EPA]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Docosahexenoic acids [DHA]
Food compositions, function of food ingredients or processes for food or foodstuffs
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on hydrogen as donor (1.12)
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Enterobacteriales, e.g. Enterobacter
Escherichia
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Enterobacteriales, e.g. Enterobacter
Salmonella
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Oxidoreductases acting on hydrogen as donor (1.12)
Oxidoreductases acting on hydrogen as donor (1.12) with NAD+ or NADP+ as acceptor (1.12.1)
Hydrogen dehydrogenase (1.12.1.2)
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Salmonella
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
Nitrilase (3.5.5.1)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Medicinal preparations containing peptides
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Fusion polypeptide
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Special targeting system for viral vectors
Vectors comprising a targeting moiety
Vectors comprising as targeting moiety peptide derived from defined protein
Vectors comprising as targeting moiety peptide derived from defined protein from viruses
Vectors comprising as targeting moiety peptide derived from defined protein from viruses dsDNA viruses
Adenoviridae
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Translation products from oncogenes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Oligonucleotides characterized by their use
Prognosis of disease development
Oligonucleotides characterized by their use
Methylation markers
Assays involving biological materials from specific organisms or of a specific nature
Translation products from oncogenes
Treatment of coagulated rubber
Purification
Medicinal preparations containing antigens or antibodies
Allergens
Drugs for immunological or allergic disorders
Immunomodulators
Immunosuppressants, e.g. drugs for graft rejection
Drugs for immunological or allergic disorders
Antiallergic agents
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
Treatment of rubber latex
Chemical or physical treatment of rubber latex before or during concentration
Purifying; Deproteinising
Medicinal preparations containing peptides
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Accessory food factors for animal feeding-stuffs
Organic substances
Enzymes
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging
Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging using microorganisms or enzymes
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on beta-1,4-glucosidic bonds
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on beta-1,4-glucosidic bonds
Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Xylanases
Hydrolases acting on ester bonds (3.1)
Carboxylic ester hydrolases (3.1.1)
Feruloyl esterase (3.1.1.73)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,4-beta-xylanase (3.2.1.8)
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Penicillium
Technologies relating to agriculture, livestock or agroalimentary industries
Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
Re-use of by-products of food processing for fodder production
Preparation of carboxylic acids or their salts, halides or anhydrides
Separation; Purification; Stabilisation; Use of additives
Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
Preparation of carboxylic acids or their salts, halides or anhydrides
Separation; Purification; Stabilisation; Use of additives
Preparation of carboxylic acids or their salts, halides or anhydrides
Separation; Purification; Stabilisation; Use of additives
Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of breast
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Oligonucleotides characterized by their use
Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Oligonucleotides characterized by their use
Prognosis of disease development
Oligonucleotides characterized by their use
Expression markers
Detection or diagnosis of diseases
Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Chemistry: analytical and immunological testing
Chemistry: analytical and immunological testing including sample preparation
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Plant toxins
Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the prostate
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Recovery or purification
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Active agents used in cell culture processes, e.g. differentation
Enzymes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Methods of production or purification of viral material
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Fused cells, e.g. hybridomas
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Regulators; Modulating activity
Regulators; Modulating activity stimulating, promoting or activating activity
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Genetically modified animals
Animals comprising random inserted nucleic acids (transgenic)
Fusion polypeptide
Fusion polypeptide containing domain for protein-protein interaction
Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
Uses of viruses
Uses of viruses as vector
Uses of viruses as vector for the expression of a heterologous nucleic acid
Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
Thiazoles
Thiazoles condensed with heterocyclic ring systems
Drugs for dermatological disorders
Anti-acne agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00-C07D507/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00-C07D507/00 in which the condensed system contains four or more hetero rings
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of nitrogen-containing organic compounds
Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Methods of production or purification of viral material
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Methods of production or purification of viral material
Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription from viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Reverse transcribing RNA viruses
Details
Retroviridae
Human Immunodeficiency Virus, HIV
Human Immunodeficiency Virus, HIV concerning HIV gagpol
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Orthomyxoviridae
Influenzavirus A, i.e. influenza A virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Orthomyxoviridae
Influenzavirus A, i.e. influenza A virus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Nucleic acids vectors
Plasmid DNA
Plasmid DNA episomal vectors
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Vector systems having a special element relevant for transcription
Vector systems having a special element relevant for transcription from viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Drugs for immunological or allergic disorders
Medicinal preparations containing antigens or antibodies
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with a leaven or a composition containing acidifying bacteria
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Sweetmeats; Confectionery; Marzipan; Coated or filled products
Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
Chewing gum
Chewing gum characterised by the composition containing organic or inorganic compounds
Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
Honey; Honey substitutes
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for disorders of the alimentary tract or the digestive system
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Drugs for dermatological disorders
Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for disorders of the muscular or neuromuscular system
Muscle relaxants, e.g. for tetanus or cramps
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system
Centrally acting analgesics, e.g. opioids
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Anti-Parkinson drugs
Drugs for disorders of the nervous system
Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Drugs for disorders of the senses
Ophthalmic agents
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the endocrine system
Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Culture media for cell or tissue culture
Specific components of cell culture medium
Undefined extracts
Undefined extracts from animals
Undefined extracts from animals from mammals
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by endocrine cells
Coculture with; Conditioned medium produced by endocrine cells thyroid, parathyroid cells
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by tumour cells
Use of cells in diagnostics
Drug screening
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
Ultrafiltration; Microfiltration
Ultrafiltration
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
[b, e]- or [b, f]-condensed with six-membered rings
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Nitrogen as only ring hetero atom containing a six-membered hetero ring
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Micromonospora
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
Reclamation of contaminated soil
Reclamation of contaminated soil microbiologically, biologically or by using enzymes
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Ethanol, i.e. non-beverage
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Specific hybridization probes
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Paramyxoviridae, e.g. parainfluenza virus
Drugs for disorders of the respiratory system
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Paramyxoviridae, e.g. respiratory syncytial virus
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Viruses
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus expressing foreign proteins
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Metapneumovirus, e.g. avian pneumovirus
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
Details
Paramyxoviridae
Respirovirus, e.g. Bovine, human parainfluenza 1,3
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Oligonucleotides characterized by their use
Expression markers
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving non-enzymic blood coagulation factors
Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
Chemistry: molecular biology and microbiology
Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
Chemistry: analytical and immunological testing
Chemistry: analytical and immunological testing including sample preparation
Digestion or removing interfering materials
Chemistry: analytical and immunological testing
Chemistry: analytical and immunological testing including sample preparation
Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
Preparation of compounds containing saccharide radicals
Monosaccharides
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Antineoplastic agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Animal cells
Tumor cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Drugs for disorders of the metabolism
Drugs for disorders of the metabolism for glucose homeostasis
Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Drugs for disorders of the cardiovascular system
Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Lysis of microorganisms
Lysis of microorganisms by physical methods
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
Phenylalanine dehydrogenase (1.4.1.20)
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Phenylalanine
Preparation of compounds containing at least three condensed carbocyclic rings
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with a cytochrome as acceptor (1.2.2)
Formate dehydrogenase (cytochrome) (1.2.2.1)
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing the quinoid structure
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Eicosapentaenoic acids [EPA]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
Dyes of natural origin prepared from natural sources, e.g. vegetable sources
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Eicosapentaenoic acids [EPA]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Docosahexenoic acids [DHA]
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
Drugs for immunological or allergic disorders
Antiallergic agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Artificially induced pluripotent stem cells, e.g. iPS
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Active agents used in cell culture processes, e.g. differentation
Cytokines; Chemokines
Interleukins [IL]
Leukemia inhibitory factor [LIF]
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by non-embryonic pluripotent stem cells
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by germ cells
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Adipocytes
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Osteocytes, osteoblasts, odontoblasts
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Chondrocytes
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Adult fibroblasts
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Cardiomyocytes
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Skeletal muscle cells, myocytes, myoblasts, myotubes
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Tenocytes, cells from tendons and ligaments
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Smooth muscle cells
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Mesenchymal stem cells
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Mesenchymal stem cells
Bone marrow mesenchymal stem cells (BM-MSC)
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Mesenchymal stem cells
Dental pulp stem cells, dental follicle stem cells
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Mesenchymal stem cells
Blood-borne mesenchymal stem cells, e.g. Msc from umbilical cord blood
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Mesenchymal stem cells
Mesenchymal stem cells from hair follicles
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Mesenchymal stem cells
Adipose-derived stem cells [ADSC], adipose stromal stem cells
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Mesenchymal stem cells
Mesenchymal stem cells from other natural sources
Coculture with; Conditioned medium produced by
Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
Bone marrow stromal cells; whole marrow
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Consortia of bacteria
Reclamation of contaminated soil
Reclamation of contaminated soil microbiologically, biologically or by using enzymes
Biological treatment of water, waste water, or sewage
Aerobic processes
Activated sludge processes
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Biological treatment of water, waste water, or sewage characterised by the microorganisms used characterised by the enzymes used
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Biological treatment of water, waste water, or sewage characterised by the microorganisms used for digestion of grease, fat, oil
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Processes involving microorganisms of different genera in the same process, simultaneously
Treatment of water, waste water, or sewage
Devices for separating or removing fatty or oily substances or similar floating material
Nature of the contaminant
Organic compounds
Hydrocarbons, e.g. oil
Nature of the water, waste water, sewage or sludge to be treated
Seawater, e.g. for desalination
General aspects of water treatment
Temperature conditions for biological treatment
Psychrophilic treatment
Use of specific compounds during water treatment
Nutrients for stimulating the growth of microorganisms
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Technologies for wastewater treatment
Biological treatment of water, waste water, or sewage
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing antigens or antibodies
Viral antigens
Medicinal preparations containing antigens or antibodies
Viral antigens
Herpetoviridae, e.g. herpes simplex virus
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antivirals for DNA viruses for herpes viruses
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus avirulent or attenuated
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Methods of inactivation or attenuation
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Herpesviridae
Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus subtilis ; Hay bacillus; Grass bacillus
Medicinal preparations containing antigens or antibodies
Bacterial antigens
Specific bacteria not otherwise provided for
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Inorganic compounds
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Bacterial cells; Fungal cells; Protozoal cells
Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Veterinary vaccine
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Adenoviral vectors
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Recovery or purification
Packaging cell lines, e.g. transcomplementing cell lines, for production of virus
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Use of virus, viral particle or viral elements as a vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Methods of production or purification of viral material
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Adenoviridae
Mastadenovirus, e.g. human or simian adenoviruses
Methods of production or purification of viral material
Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Vector systems having a special element relevant for transcription
Vectors comprising a special translation-regulating system
Vectors comprising a special translation-regulating system translation of more than one cistron
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Non condensed pyridines; Hydrogenated derivatives thereof
Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Hinge
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Mannanases
Beta-mannosidase (3.2.1.25), i.e. mannanase
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Amino acids, peptides or proteins
Proteins from microorganisms
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Pretreatment of feeding-stuffs with enzymes
Accessory food factors for animal feeding-stuffs
Organic substances
Steroids
Accessory food factors for animal feeding-stuffs
Organic substances
Enzymes
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for swines
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Beta-mannosidase (3.2.1.25), i.e. mannanase
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Polycarboxylic acids
Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
Bioreactors or fermenters specially adapted for specific uses
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Adaptation or attenuation of cells
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Antineoplastic agents
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Food compositions, function of food ingredients or processes for food or foodstuffs
Function of food ingredients
Foods, ingredients or supplements having a functional effect on health
Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
Lactic or propionic acid bacteria
Lactobacillus
Plantarum
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus plantarum
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Other non-alcoholic beverages
Other non-alcoholic beverages fermented
Tea; Tea substitutes; Preparations thereof
Tea extraction; Tea extracts; Treating tea extract; Making instant tea
Addition of, or treatment with, enzymes or microorganisms
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Concentrates of non-alcoholic beverages
Preparation of other alcoholic beverages
Preparation of other alcoholic beverages by fermentation
Preparation of other alcoholic beverages by fermentation of botanical family Poaceae, e.g. wheat, millet, sorghum, barley, rye, or corn
Preparation of other alcoholic beverages
Preparation of other alcoholic beverages by fermentation
Low-alcohol beverages
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Oligonucleotides characterized by their use
Expression markers
Detection of programmed cell death, i.e. apoptosis
Detection or diagnosis of diseases
Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Tryptophan
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Expression systems using regulatory sequences derived from the trp-operon
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
Integrated devices, or assemblies of multiple devices, comprising at least one organic light-emitting element covered by group H10K50/00
OLED displays
Active-matrix OLED [AMOLED] displays
Interconnections, e.g. wiring lines or terminals
Organic light-emitting devices
Constructional details
Electrodes
Cathodes
Multilayers, e.g. opaque multilayers
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Lactic or propionic acid bacteria
Lactobacillus
Rhamnosus
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antineoplastic agents
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Framework region [FR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Stability, e.g. half-life, pH, temperature or enzyme-resistance
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Medicinal preparations containing antigens or antibodies
Vertebrate antigens
Cancer antigens
Medicinal preparations containing antigens or antibodies
Vertebrate antigens
Cancer antigens
Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; PAP or PSGR
Prostate specific membrane antigen [PSMA]
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Plant toxins
Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of prostate
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Rescue devices or other safety devices, e.g. safety chambers or escape ways
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus thuringiensis
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Angiogenesic factors; Angiogenin
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Comprising a combination of two or more separate antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of nitrogen-containing organic compounds
Preparation of elements or inorganic compounds except carbon dioxide
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Clostridium
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
Organic compounds; Microorganisms; Enzymes
Microorganisms; Enzymes
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Preserving finished, partly finished or par-baked bakery products; Improving
Treatment of flour or dough by adding materials thereto before or during baking
Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
Organic nitrogen compounds
Proteins
Microbial proteins
Preservation of edible seeds, e.g. cereals
Preserving with chemicals
Preserving with chemicals in the form of liquids or solids
Organic compounds; Microorganisms; Enzymes
Microorganisms; Enzymes; Antibiotics
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
Organic compounds; Microorganisms; Enzymes
Antibiotics
Reclamation of contaminated soil
Reclamation of contaminated soil chemically
Reclamation of contaminated soil
Reclamation of contaminated soil microbiologically, biologically or by using enzymes
Reclamation of contaminated soil microbiologically, biologically or by using enzymes using fungi or plants
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
Urease (3.5.1.5)
In situ
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
N-glycosides
Nucleotides
Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Ligases (6)
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Glutamic acid; Glutamine
Preparation of compounds containing saccharide radicals
Preparation of nitrogen-containing carbohydrates
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carbonyl group
Ketones
Acetone-containing products
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Polycarboxylic acids
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Polycarboxylic acids
Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Polycarboxylic acids
Tricarboxylic acids, e.g. citric acid
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Polyesters of hydroxy carboxylic acids
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
2-Hydroxy-3-oxopropionate reductase (1.1.1.60)
Oxidoreductases acting on the CH-OH group of donors (1.1)
Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
Hydroxypyruvate reductase (1.1.1.81)
Carbon-carbon lyases (4.1)
Carboxy-lyases (4.1.1)
Tartronate-semialdehyde synthase (4.1.1.47)
Carbon-carbon lyases (4.1)
Oxo-acid-lyases (4.1.3)
Malyl-CoA lyase (4.1.3.24)
Ligases forming carbon-sulfur bonds (6.2)
Acid-Thiol Ligases (6.2.1)
Malate--CoA ligase (6.2.1.9)
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Medicinal preparations containing active ingredients not provided for in groups A61K31/00-A61K41/00
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Lung
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00-A61K41/00
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Fusion polypeptide
Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Fusion polypeptide
Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
Oligonucleotides characterized by their use
Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Oligonucleotides characterized by their use
Expression markers
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving proteins of known structure or function as defined in the subgroups
Detection or diagnosis of diseases
Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Drugs for disorders of the respiratory system
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Integrin superfamily
Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
General methods for enhancing the expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Preparation of peptides or proteins
Preparation of peptides or proteins
Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Preparation of compounds containing saccharide radicals
Monosaccharides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Intramolecular oxidoreductases (5.3)
Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
Arabinose isomerase (5.3.1.3)
Intramolecular oxidoreductases (5.3)
Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
L-Arabinose isomerase (5.3.1.4)
Technologies relating to chemical industry
Improvements relating to the production of bulk chemicals
Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Adaptation or attenuation of cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Clostridium
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Epidermal growth factor [EGF], i.e. urogastrone
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Hormones
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DNA sequences coding for fusion proteins
DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
Fusion polypeptide
Fusion polypeptide containing domain for protein-protein interaction
Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Reverse transcribing DNA viruses
Details
Hepadnaviridae
Orthohepadnavirus, e.g. hepatitis B virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Lysine; Diaminopimelic acid; Threonine; Valine
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
Medicinal preparations containing antigens or antibodies
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Nucleotidyltransferases (2.7.7)
DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Colony-stimulating factor [CSF]
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Isolated enzymes; Isolated proteins
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
Medicinal preparations containing peptides
Fusion polypeptide
Accessory food factors for animal feeding-stuffs
Organic substances
Enzymes
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
Medicinal preparations containing peptides
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Xylan endo-1,3-beta-xylosidase (3.2.1.32), i.e. endo-1-3-beta-xylanase
Methods for preparing or baking dough
Methods for preparing dough; Treating dough prior to baking
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with yeasts
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for fungi
Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Glucanases
Glucanases acting on alpha -1,4-glucosidic bonds
Amylases
Alpha-amylase (3.2.1.1.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on glycosyl compounds (3.2)
Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Hemicellulases not provided in a preceding group
Xylanases
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Alpha-amylase (3.2.1.1)
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Endo-1,4-beta-xylanase (3.2.1.8)
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Hybridisation assays
Hybridisation assays for detection of mutation or polymorphism
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Animal cells
White blood cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving proteins of known structure or function as defined in the subgroups
Details
Lipocortins
Chemistry: analytical and immunological testing
Test for named disease, body condition or organ function
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Preparation of compounds containing at least three condensed carbocyclic rings
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Medicinal preparations containing peptides
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
Serine endopeptidases (3.4.21)
Thrombin (3.4.21.5)
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Enzymes; Proenzymes; Derivatives thereof
Hydrolases (3)
Hydrolases (3) acting on peptide bonds (3.4)
Antineoplastic agents
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
Serine endopeptidases (3.4.21)
Thrombin (3.4.21.5)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Acyltransferases (2.3)
Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acid esters
Glycerides
Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes
Preparation of compounds or compositions, not provided for in groups C12P3/00-C12P39/00, by using microorganisms or enzymes by using bacteria
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Receptors; Cell surface antigens; Cell surface determinants
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Medicinal preparations containing antigens or antibodies
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Aspergillus
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using fungi
Aspergillus
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Virus
Virus-like particles
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the route of administration
Mucosal route
Mucosal route oral/gastrointestinal
Medicinal preparations containing antigens or antibodies
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Reoviridae
Rotavirus, e.g. rotavirus A
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Colony-stimulating factor [CSF]
Granulocyte CSF; Granulocyte-macrophage CSF
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Fusion polypeptide
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
Preparation of compounds containing saccharide radicals
Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Carrier-bound or immobilised peptides; Preparation thereof
Peptides being immobilised on, or in, an organic carrier
Libraries per se, e.g. arrays, mixtures
Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
Simultaneous synthesis of different peptide species; Peptide libraries
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Processes for the isolation, preparation or purification of DNA or RNA
Isolating an individual clone by screening libraries
Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Fatty acids or derivatives thereof; Fats or oils
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Methods for controlling, regulating or enhancing expression of transgenes in plant cells
Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
Reproductive tissue-specific promoters
Male-specific, e.g. anther, tapetum, pollen
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
Male sterility
Food compositions, function of food ingredients or processes for food or foodstuffs
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Genetically Modified [GMO] plants, e.g. transgenic plants
Preparation of peptides or proteins
Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for E. coli
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Escherichia (G)
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
Beta-endorphins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DNA sequences coding for fusion proteins
DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
Fusion polypeptide
Fusion polypeptide containing domain for protein-protein interaction
Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
Regulators; Modulating activity
Inhibitors; Suppressors
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Medicinal preparations containing peptides
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of nitrogen-containing organic compounds
Alpha- or beta- amino acids
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Rhizobium
Compounds containing elements of Groups 5 or 15 of the Periodic Table
Phosphorus compounds
Phosphorus compounds with one or more PC bonds
Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
Drugs for dermatological disorders
Compounds containing elements of Groups 5 or 15 of the Periodic Table
Phosphorus compounds
Phosphorus compounds with one or more PC bonds
Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
Acyclic saturated acids which can have further substituents on alkyl
Compounds containing elements of Groups 5 or 15 of the Periodic Table
Phosphorus compounds
Phosphorus compounds with one or more PC bonds
Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
Acyclic unsaturated acids
Anti-perspirants or body deodorants
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
Phosphorus compounds
Compounds containing elements of Groups 5 or 15 of the Periodic Table
Phosphorus compounds
Phosphorus compounds with one or more PC bonds
Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
Acyclic saturated acids which can have further substituents on alkyl
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Biological properties of particular ingredients
Enzyme modulators, e.g. Enzyme agonists
Enzyme inhibitors; Enzyme antagonists
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Escherichia
Escherichia coli
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Yeast isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Candida
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Medicinal preparations containing antigens or antibodies
Haptens or antigens, bound to carriers
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for RNA viruses
Antivirals for RNA viruses for HIV
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antivirals for DNA viruses
Antivirals for DNA viruses for herpes viruses
Antiparasitic agents
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
Hepadnaviridae, e.g. hepatitis B virus
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Cells from the blood or the immune system
Dendritic cells, e.g. Langherhans cells in the epidermis
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Animal cells
Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
Proteins
Antibodies
Medicinal preparations containing peptides
Medicinal preparations containing antigens or antibodies
Fusion polypeptide
Fusion polypeptide containing a localisation/targetting motif
Fusion polypeptide
Fusion polypeptide containing domain for protein-protein interaction
Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
Reverse transcribing DNA viruses
Details
Hepadnaviridae
Orthohepadnavirus, e.g. hepatitis B virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
Details
Flaviviridae
Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Comprising a combination of two or more separate antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Fab or Fab'
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interleukins [IL]
IL-2
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Metal-working machines incorporating a plurality of sub-assemblies, each capable of performing a metal-working operation
Driving or feeding mechanisms; Control arrangements therefor
Driving main working members
Driving main working members rotary shafts, e.g. working-spindles
Accessories for spindle drives
Preparation of nitrogen-containing organic compounds
Carnitine; Butyrobetaine; Crotonobetaine
Metal-working machines incorporating a plurality of sub-assemblies, each capable of performing a metal-working operation
Machines with twin spindles
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Specific hybridization probes
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Viruses; Subviral particles; Bacteriophages
Reovirus; Rotavirus
Antineoplastic agents
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Reoviridae
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Reoviridae
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Reoviridae
Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Fused cells, e.g. hybridomas
Plant cells
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen as only ring hetero atom
Nitrogen as only ring hetero atom containing a six-membered hetero ring
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
Amidase (3.5.1.4)
Carbon-oxygen lyases (4.2)
Hydro-lyases (4.2.1)
Nitrile hydratase (4.2.1.84)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Chemistry: molecular biology and microbiology
Microorganisms
Microorganisms using bacteria or actinomycetales
Methylomonas
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Aldonic, ketoaldonic or saccharic acids
2-Ketogulonic acid
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Isomerases (5.)
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Intramolecular oxidoreductases (5.3)
Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
Triose-phosphate isomerase (5.3.1.1)
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of breast
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of colon
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of ovaries
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Antineoplastic agents
Antineoplastic agents specific for metastasis
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of breast
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of colon
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of liver, pancreas or kidney
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for birds
Feeding-stuffs specially adapted for particular animals for birds for poultry
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Dietetic or nutritional methods, e.g. for losing weight
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Drugs for disorders of the metabolism
Anorexiants; Antiobesity agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interferons [IFN]
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Oxidoreductases (1.)
Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Detection or diagnosis of diseases
Endocrine or metabolic disorders
Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Preparations for testing in vivo
Preparation for luminescence or biological staining
Luminescence
Fluorescence in vivo
Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
Preparations for testing in vivo
Preparation for luminescence or biological staining
Luminescence
Fluorescence in vivo
Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
Antibodies
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Fused cells, e.g. hybridomas
Animal cells
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Preparation of nitrogen-containing organic compounds
Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antibacterial agents
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Antivirals
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for immunological or allergic disorders
Antiallergic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Propionic acid; Butyric acids
Food compositions, function of food ingredients or processes for food or foodstuffs
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Lactobacillus brevis
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for immunological or allergic disorders
Antiallergic agents
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Drugs for skeletal disorders
Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Drugs for skeletal disorders
Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Drugs for skeletal disorders
Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Detection or diagnosis of diseases
Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Detection or diagnosis of diseases
Determining the risk of relapse
Preparations for testing in vivo
Preparation for luminescence or biological staining
Luminescence
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for leukemia
Antineoplastic agents
Antineoplastic agents specific for metastasis
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
CD44
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of ovaries
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Pre-targeting systems involving an antibody for targeting specific cells
Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the prostate
Drugs for genital or sexual disorders; Contraceptives
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Supracellular entities, e.g. tissue, organisms
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of breast
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of colon
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Specifically defined cancers
Specifically defined cancers of liver, pancreas or kidney
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Agonist effect on antigen
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving receptors, cell surface antigens or cell surface determinants
CD44
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Antibody-dependent cellular cytotoxicity [ADCC]
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Lung
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from lung cancer cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from lung
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from liver or pancreas
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Lung
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Breast
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin the drug being a peptidic cytokine, e.g. an interleukin or interferon
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from lung cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from liver or pancreas cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from lung
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from liver or pancreas
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Lung
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Reproductive system, e.g. ovaria, uterus, testes, prostate
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Colony-stimulating factor [CSF]
Granulocyte CSF; Granulocyte-macrophage CSF
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Hormones
Growth hormone [GH], i.e. somatotropin
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Hormones
Insulins
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
DNA sequences coding for fusion proteins
Fusion polypeptide
Fusion polypeptide containing protease site
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Plant toxins
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Antineoplastic agents
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
Toxins
Plant toxins
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
Preparations containing radioactive substances for use in therapy or testing in vivo
Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
Organic compounds
Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
Antineoplastic agents
Drugs for immunological or allergic disorders
Immunomodulators
Immunostimulants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Fab or Fab'
Preparation of oxygen-containing organic compounds
Carboxylic acid esters
Polyesters of hydroxy carboxylic acids
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Pseudomonas
Pseudomonas putida
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Cells of the genital tract; Non-germinal cells from gonads
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Transferases (2.)
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interferons [IFN]
Medicinal preparations containing peptides
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interferons [IFN]
IFN-gamma
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Growth factors; Growth regulators
Erythropoietin [EPO]
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Cytokines; Lymphokines; Interferons
Interferons [IFN]
IFN-gamma
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Animal cells or tissues; Human cells or tissues
Vertebrate cells
Cells of the genital tract; Non-germinal cells from gonads
Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Cells modified by introduction of foreign genetic material
Fused cells, e.g. hybridomas
Animal cells
Preparation of peptides or proteins
Glycopeptides, glycoproteins
Glycosyltransferases (2.4)
Hexosyltransferases (2.4.1)
N-Acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (2.4.1.150)
Genetically modified cells
Cells for production
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Yeasts or derivatives thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Inorganic salts, minerals or trace elements
Complexes or chelates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Yeast isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Baker's yeast; Brewer's yeast
Saccharomyces isolates
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
Fungi
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Candida
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Saccharomyces
Saccharomyces cerevisiae
Technologies for the production of fuel of non-fossil origin
Biofuels, e.g. bio-diesel
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Liver or Pancreas
Antineoplastic agents
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Stomach, Intestines
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Other organic fertilisers
Organic fertilisers containing added bacterial cultures, mycelia or the like
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Trichoderma
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Viral vectors
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Baculoviridae
Viruses as such, e.g. new isolates, mutants or their genomic sequences
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Baculoviridae
Use of virus, viral particle or viral elements as a vector
Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
Details
Baculoviridae
Methods of production or purification of viral material
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Hybrid immunoglobulins
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
Medicinal preparations containing antigens or antibodies
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Antineoplastic agents
Antineoplastic agents
Antineoplastic agents specific for metastasis
Medicinal preparations containing antigens or antibodies
Medicinal preparations containing antigens or antibodies comprising antibodies
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Constant or Fc region; Isotype
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Complementarity determining region [CDR]
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Single chain antibody (scFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
Disulfide-stabilized antibody (dsFv)
Immunoglobulins specific features
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Immunoglobulins specific features
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Fusion polypeptide
Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
Biological material, e.g. blood, urine; Haemocytometers
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Immunoassay; Biospecific binding assay; Materials therefor
Immunoassay; Biospecific binding assay; Materials therefor for cancer
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Skin, nerves, brain
Immunoglobulins specific features
Immunoglobulins specific features characterized by their source of isolation or production
Specific host cells or culture conditions, e.g. components, pH or temperature
Immunoglobulins specific features
Immunoglobulins specific features characterized by taxonomic origin
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
Immunoglobulins specific features
Immunoglobulins specific features characterized by aspects of specificity or valency
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Immunoglobulins specific features
Immunoglobulins specific features characterized by immunoglobulin fragments
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Assays involving biological materials from specific organisms or of a specific nature
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
Assays involving proteins of known structure or function as defined in the subgroups
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the urinary system
Drugs for disorders of the urinary system of the kidneys
Drugs for disorders of the blood or the extracellular fluid
Antianaemics
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Lactic or propionic acid bacteria
Lactobacillus
Gasseri
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt in powdered, granulated or dried solid form
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the metabolism
Nutrients, e.g. vitamins, minerals
Lactic or propionic acid bacteria
Lactobacillus
Gasseri
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Animal feeding-stuffs
Animal feeding-stuffs obtained by microbiological or biochemical processes
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
Animal feeding-stuffs
Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
Feeding-stuffs specially adapted for particular animals
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Protozoa; Culture media therefor
Accessory food factors for animal feeding-stuffs
Organic substances
Fatty acids; Fats; Products containing oils or fats
Accessory food factors for animal feeding-stuffs
Organic substances
Colouring agents, e.g. pigmenting or dyeing agents
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Fatty acids or derivatives thereof; Fats or oils
Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
Colouring or decolouring of foods
Addition of dyes or pigments, e.g. in combination with optical brighteners
Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
General protective or antinoxious agents
Free radical scavengers or antioxidants
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Unicellular algae; Culture media therefor
Unicellular algae isolates
Preparation of compounds containing saccharide radicals
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
Preparation of oxygen-containing organic compounds
Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
Fatty acids
Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
Microorganisms ; Processes using microorganisms
Algae ; Processes using algae
Biological treatment of water, waste water, or sewage
Aerobic processes
Biological treatment of water, waste water, or sewage
Aerobic processes
Aerobic processes using submerged filters
Biological treatment of water, waste water, or sewage
Biological treatment of water, waste water, or sewage characterised by the microorganisms used
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Technologies for wastewater treatment
Biological treatment of water, waste water, or sewage
Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
Leguminosae or Fabaceae, e.g. soybean, alfalfa or peanut
Glycine max [soybean]
Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
Encapsulated embryos for plant reproduction, e.g. artificial seeds
Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
Seeds
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Plant sterols or derivatives thereof, e.g. phytosterols
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Magnoliophyta (angiosperms)
Magnoliopsida (dicotyledons)
Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Angiosperms [Magnoliophyta]
Magnoliopsida [dicotyledons]
Drugs for disorders of the alimentary tract or the digestive system
Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
General protective or antinoxious agents
Free radical scavengers or antioxidants
Preparations for care of the skin
Preparations for care of the skin
Anti-ageing preparations
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Extraction of the material
Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Carbon-oxygen lyases (4.2)
Hydro-lyases (4.2.1)
Nitrile hydratase (4.2.1.84)
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Adaptation or attenuation of cells
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Lyases (4.)
Preparation of nitrogen-containing organic compounds
Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
Nitrilase (3.5.5.1)
Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
Fungicides
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Viruses, e.g. bacteriophages
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
Details
Uses of virus other than therapeutic or vaccine, e.g. disinfectant
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons
Disinfectants; Antimicrobial compounds or mixtures thereof
Nematocides
Arthropodicides
Acaricides
Arthropodicides
Insecticides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
Radiation-absorbing paints
Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
Additives
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Bacillus
Bacillus cereus
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Bacteria or derivatives thereof, e.g. probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Drugs for disorders of the alimentary tract or the digestive system
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Local antiseptics
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Streptococcus ; Enterococcus; Lactococcus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Microbial fungi; Substances produced thereby or obtained therefrom
Disinfectants; Antimicrobial compounds or mixtures thereof
Fungicides
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Fungal isolates
Preparation of sulfur-containing organic compounds
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Oxygen as only ring hetero atoms
Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
Preparation of hydrocarbons or halogenated hydrocarbons
Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a hydroxy group
Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Preparation of oxygen-containing organic compounds
Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Hydroxy-carboxylic acids
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Drugs for disorders of the alimentary tract or the digestive system
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Medicinal preparations containing organic active ingredients
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
Phenols
Medicinal preparations containing organic active ingredients
Heterocyclic compounds
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
3,4-Dihydrobenzopyrans, e.g. chroman, catechin
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Drugs for disorders of the respiratory system
Drugs for immunological or allergic disorders
Drugs for immunological or allergic disorders
Antiallergic agents
Cosmetics or similar toiletry preparations
Cosmetics or similar toiletry preparations characterised by the composition
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Algae
Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
Preparations for care of the skin
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
General cosmetic use
Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
Chemical, physico-chemical or functional or structural properties of particular ingredients
Thickener, Thickening system
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the alimentary tract or the digestive system
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms ; Processes using microorganisms
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
B. thuringiensis
Plant growth regulators
Nematocides
Arthropodicides
Drugs for disorders of the nervous system
Anxiolytics
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Bifidobacteria
Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Microorganisms or materials therefrom
Bacteria
Probiotics
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Lactobacilli, e.g. L. acidophilus or L. brevis
Drugs for disorders of the nervous system
Antidepressants
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Fungi; Culture media therefor
Yeasts; Culture media therefor
Yeast isolates
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
Accessory food factors for animal feeding-stuffs
Organic substances
Sugars; Polysaccharides
Accessory food factors for animal feeding-stuffs
Organic substances
Colouring agents, e.g. pigmenting or dyeing agents
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for horses
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Feeding-stuffs specially adapted for particular animals
Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
Foods or foodstuffs containing additives; Preparation or treatment thereof
Organic compounds
Organic compounds containing oxygen as heteroatom
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Plant extracts, their artificial duplicates or their derivatives
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Genes encoding for enzymes or proenzymes
Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
Accessory food factors for animal feeding-stuffs
Organic substances
Aliphatic or alicyclic compounds
Accessory food factors for animal feeding-stuffs
Organic substances
Aromatic compounds
Accessory food factors for animal feeding-stuffs
Organic substances
Amino acids; Derivatives thereof
Accessory food factors for animal feeding-stuffs
Organic substances
Vitamins
Food compositions, function of food ingredients or processes for food or foodstuffs
Genetically modified cells
Cells for production
Microorganisms ; Processes using microorganisms
Fungi ; Processes using fungi
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
Adding ingredients
Acidifying substances
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
Milk preparations; Milk powder or milk powder preparations
Fermented milk preparations; Treatment using microorganisms or enzymes
Fermented milk preparations; Treatment using microorganisms or enzymes using additives
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Lactobacillus
Plant growth regulators
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
Bacteria; Substances produced thereby or obtained therefrom
Bacillus
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Bacterial isolates
Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
Bacteria; Culture media therefor
Preparation of elements or inorganic compounds except carbon dioxide
Microorganisms ; Processes using microorganisms
Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Recombinant DNA-technology
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Vectors or expression systems specially adapted for eukaryotic hosts
Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
Phenotypically and genetically modified plants via recombinant DNA technology
Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Hydrolases (3)
Hydrolases (3) acting on ester bonds (3.1)
Ribonucleases RNAses, DNAses
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change